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Kidney stone disease is a world-wide problem that affects about 10-15% of the general 
population. Although the direct cause of kidney stone formation is not known, reports have 
suggested it is probably a multifactorial disease. Lactobacillus strains which potentially had 
increased ability to degrade oxalate were previously isolated from a healthy low kidney stone risk 
group. The aim of this study was to identify these natural Lactobacillus strains and evaluate their 
potential for use as probiotics in reducing the risk of kidney stone disease. Identification was 
achieved by PCR amplification and sequencing of the 16S rRNA gene and the 16S-23S rRNA 
internal transcribed spacer (ITS) region. The strains were identified as follows; Lactobacillus 
gasseri 7(3), L. gasseri 17(4), Lactobacillus reuteri 17(7) and L. reuteri 16(9). Their probiotic 
characteristics were also evaluated, by determining their antibiotic susceptibility profiles, their 
antimicrobial activity, adhesion ability, and their acid and bile tolerance levels. The strains were 
also examined for their oxalate degrading activity, and overall they were shown to be potential 
probiotic strains with good oxalate degrading ability. The strains were also examined at the 
genetic level with regard to the regulation of the oxc gene encoding the oxalyl-CoA 
decarboxylase enzyme that assists in degrading oxalate. Among the 4 Lactobacillus strains, L. 
gasseri 7(3) strain possessed both good probiotic properties and had the highest oxalate 
degrading activity. Thus, it was selected for study of the further transcriptional regulation of oxc 
gene in the presence or absence of 10 mM ammonium oxalate under pH 6.8 and 5.5 conditions. 
Dot blot analysis confirmed that oxc gene was constitutively transcribed under both pH 
conditions in presence or absence of 10 mM oxalate. This suggests that L. gasseri 7(3) possesses 
a “generalist” oxalate-degrading character due to the fact that it can utilize alternative substrates 
as source of energy other than oxalate. This finding indicated that L. gasseri 7(3) could possibly 
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1.1. Kidney stones 
Kidney stone disease (or nephrolithiasis) is a common, worldwide problem that affects 
approximately 6-10% of the general population (Mittal and Kumar, 2004). Treatment is costly and 
the disease is defined as a painful urological disorder (Taylor and Curhan, 2007). It is estimated that 
more men have kidney stones than women (Bihl and Meyers, 2001). In South Africa, the problem 
extends to race, with 15% of white men and 5% of white women being prone to kidney stone 
formation, as opposed to less than 1% in the black population (Whalley et al., 1998). The reasons for 
the disparity of kidney stone formation between the two population groups are not so far understood, 
as the direct cause of stones formation is unknown and probably multifactorial (Heller, 1999). One of 
the contributing factors is likely to be the supersaturation of urine with the respect to its constituents 
such as calcium, oxalate and uric acid among others (Woolfson and Mansell, 1994). This 
supersaturation may lead to the formation of crystals, which attach to the inner surface of the kidney 
and build up into kidney stones. However, it should be noted that, supersaturation is not the only 
contributing factor to the formation of kidney stones, as there are other factors involved in stone 
formation (see section 1.1.1). 
Several types of stones can be formed and these are categorized based on their chemical 
composition. Approximately 80% of stones are made up of calcium oxalate and, less often, calcium 
phosphate. Of the remaining, 10% are composed of struvite (which forms in the presence of urine 
infection and is made up of a mixture of magnesium, ammonia and phosphate), 9% contain uric acid 
(which occurs when the acidity level in urine is high), and only 1% contain cystine.  The latter is a 
rare phenomenon and occurs mainly in an inherited condition called cystinuria (Coe et al., 2005).  
2 
 
1.2. The risk factors for kidney stones 
There are numerous factors that may increase the risk of kidney stone formation, such as gender, age, 
ethnicity, family history, geographical factors, diet or medicine, as reviewed in detail below. 
 
1.2.1 Gender and Age 
As previously explained, gender has been shown to have an effect on the formation of kidney stones, 
with the condition affecting men more than women (Bergsland et al., 2002). This could possibly be 
due to higher supersaturation in the urine of men as compared to women (Parks et al., 1997). Other 
studies have suggested that oestrogen may also play a role in the reduced risk of kidney stones in 
women (Heller et al., 2002). Oestrogen is a female hormone that has been suggested to shield 
women from the formation of kidney stone. Age is also another factor that may influence the kidney 
stone formation. Studies have shown that older individuals have a higher incidence of kidney stone 
disease than young adults; however, the cause of this age effect is not clearly understood (Yagisawa 
et al., 1999). 
 
1.2.2. Ethnicity and Family history 
 
According to Soucie et al. (1994), the prevalence of kidney stones in United States of America was 
higher among white people as compared to black people. This has also been observed in South 
Africa where approximately, 15% of the male white population are at risk of formation of kidney 
stones as compared to less than 1% of the black population (Whalley et al., 1998). Family history is 
considered to be another contributing factor. Curhan et al. (1997) reported that, the prevalence of 
kidney stones is higher among people whose families have had a history of kidney stones as 
compared to those whose families had no kidney stones. The causes of this phenomenon have, 
however, not yet been understood.  
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1.2.3. Geographical factors 
The geographical difference in the pattern of kidney stone disease incidence has been examined for 
decades. It is thought that the kidney stone disease is more commonly found in dry regions as 
compared to wet regions (Chandrajith et al., 2006). For instance, in the south-eastern part of Turkey, 
urolithiasis has been shown to be endemic, probably due to the hot climate, which may lead to 
dehydration or fluid loss (Ece et al., 2000). It is believed that the dehydration process could lead to 
the increase in urinary concentration and thereby result in kidney stone formation. Interestingly, in 
other parts of the world such as South Africa, the hot climate has not been shown to play a role in 
kidney stone disease, as the incidence of disease is low (Whalley et al., 1998). This may indicate that 
the assumption of a correlation between climate and kidney stone incidence is not valid. 
 
1.2.4. Diet  
Numerous studies have reported that there is a link between diet and kidney stones. Curhan et al. 
(1993) found that high intake of calcium in the diet lowered the risk of kidney stone disease. On the 
other hand, a low-calcium diet has been shown to possibly lead to greater absorption of oxalate from 
the bowel into the urine, and this leads to calcium oxalate formation (von Unruh et al., 2004). 
Previous studies have determined that the risk of developing hyperoxaluria (excessive oxalate 
present in the urine) is caused by high intake of oxalate, which may result in excessive absorption of 
oxalate due to low availability of calcium in the intestine (Siener et al., 2003) as illustrated in Fig. 
1.1. It is understood that the combination of oxalate and calcium in the gut reduces the risk of kidney 
stone formation, as it lessens the availability of oxalate for absorption in the intestine. In addition, 
patients who suffer from kidney stone disease are advised to maintain a high fluid intake to lessen 
the incidence of concentrated urine. Taylor et al. (2004) reported that high intake of magnesium was 




Figure 1.1. The route shows the intake of the ingested oxalate or oxalate precursors (Kleinman, 2007). 
 
1.2.5. Medication  
Several authors have indicated that some medications may increase the risk of kidney stone 
formation. Kuo et al. (2002) reviewed cases of topiramate-induced nephrolithiasis as described in the 
urologic literature. Topiramate is a drug which is commonly prescribed for the treatment of migraine 
headaches, and seizure disorders. It was found that treatment with topiramate might cause metabolic 
acidosis in patients by inhibiting the activity of carbonic anhydrase. Moreover, topimarate may cause 
distal tubular acidification which may eventually lead to kidney stone formation. Indinavir has also 
been shown to contribute in the increased risk of developing kidney stone. Indinavir is an HIV-1 
protease inhibitor, a medicine that is used to treat patients with HIV infection (Hogg et al., 1997; 







1.3. Treating and prevention of kidney stone formation  
For many decades, kidney stones have been treated by means of therapeutic drugs, surgery and other 
preventative measures. Moreover, the primary treatment given to most patients with kidney stones, is 
to consume large amounts of fluids or be given water by intravenous infusion, if nauseous (Bihl and 
Meyers, 2001). Patients are also encouraged by their doctors to eat food that is rich in calcium and 
avoid food rich in oxalate such as nuts, chocolate or spinach (Woolfson and Mansell, 1994). 
Therapeutic drugs such as thiazides are the most commonly used class of drugs, but potassium 
citrate, tiopronin and allopurinol may also be helpful to treat kidney stones (Ingelfinger, 2002).  
In some cases, it may be difficult to manage the stone especially if it is larger than 5 mm or blocks 
the flow of urine. Urological procedures such as extracorporeal shockwave lithotripsy (ESWL), 
percutaneous nephrolithotomy and ureteroscopy have, therefore, been introduced to get rid of the 
stones (Lingeman et al., 2003; Knoll, 2007). However, all these treatments may have their side 
effects and may cause substantial renal or ureteral damage. Therefore, an alternative option for the 
treatment of kidney stone disease without the use of drugs or surgery is needed. Treatment with 
oxalate degrading bacteria could be a new therapeutic choice for the treatment of kidney stone 
disease.  
 
1.4. Oxalate and kidney stone disease 
Oxalate is a toxic compound found in variety of food such as sweet potato, chocolate and tea 
(Stewart et al., 2004; Holmes and Kennedy, 2000). Humans lack the enzymes needed to metabolize 
oxalate. It is therefore, excreted unchanged in the urine by the kidneys or eliminated in the faeces. 
(Morton et al., 2002; Kolandaswamy et al., 2009). However, the increased absorption of oxalate-rich 
food in the gut could be dangerous, as this may lead to the formation of calcium oxalate stones 
(Argenzio et al., 1988). The oxalate-degrading ability of several bacteria such as Oxalobacter 
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formigenes, has therefore, been studied with a view to their possibility use in the prevention of 
kidney stone disease. 
 
1.5. Oxalobacter formigenes 
The oxalate degrading activity of bacteria is known to be essential in regulating oxalate homeostasis 
(Sidhu et al., 1998; Stewart et al., 2004). O. formigenes in particular has attracted world-wide 
attention for its oxalate-degrading ability (Allison et al., 1985). This bacterium uses oxalate as its 
source of energy; furthermore, numerous studies have suggested that there is a correlation between 
the absence of O. formigenes in the gut and higher urinary oxalate concentration and increased risk 
of hyperoxaluria (Anantharam et al., 1989; Troxel et al., 2003; Sidhu et al., 1998). O. formigenes has 
been shown to use two enzymes for the degradation of oxalate. These are oxalyl-CoA decarboxylase, 
which decarboxylates an activated oxalate molecule, and formyl-CoA transferase, which activates an 
oxalate molecule by cycling the CoA moiety from formyl-CoA (Sidhu et al., 1997). This reaction is 
illustrated in Fig. 1.2. 
 
Figure 1.2. Oxalate catabolism of O. formigenes (Mittal and Kumar, 2004). 
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Oxalate catabolism by O. formigenes is triggered by the transport of oxalate into the cell. It is then 
converted to oxalyl-CoA by the transfer of Coenzyme A from formyl-CoA (catalysed by the formyl-
CoA transferase enzyme). Thereafter, oxalyl-CoA is decarboxylated to formyl-CoA and CO2 by 
oxalyl-CoA decarboxylase, with diffusion of CO2 out of the cell. The CoA is transferred from 
formyl-CoA to an incoming molecule of oxalate and formate is released from the cell through an 
antiporter. An antiporter (OxlT) is a membrane protein that mediates the exchange of oxalate and 
formate (Ruan et al., 1992). However, for every molecule that is oxalyl-CoA decarboxylated, there is 
proton consumption, and this leads to the maintenance of a proton gradient that generates ATP 
synthesis (Mittal and Kumar, 2004). The genes encoding the oxalyl-CoA decarboxylase and the 
formyl-CoA transferase were identified as the oxc and frc genes, respectively (Lung et al., 1994; 
Sidhu et al., 1997). The antiporter protein, oxlT gene has also been identified in O. formigenes (Abe 
et al., 1996). Oxc is the most studied gene, and thus it was of special interest to study and evaluate its 
ability to reduce increased risk of kidney stone disease. 
 
1.6. Other oxalate degrading bacteria 
Besides O. formigenes, there are other enteric bacteria such as, Enterococcus faecalis (Hokama et 
al., 2000), Providentia rettgeri (Hokama et al., 2005), Eubacterium lentum (Ito et al., 1996) 
Bifidobacterium infantis (Campieri et al., 2001), Lactobacillus and Bifidobacterium spp (Campieri et 
al., 2001; Lewanika et al., 2007; Turroni et al., 2007) that have shown their potential ability to 
degrade oxalate. Among the aforementioned bacteria, O. formigenes is considered as a “specialist” 
oxalotroph, as it uses oxalate as its sole source of energy or carbon (Sahin, 2003; Allison et al., 
1985). The other bacteria are defined as “generalist” oxalotrophs and they are able to use a variety of 
substrates as well as oxalate as their source of energy.  
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The focus of the present study is, however, on Lactobacillus species, and the possible role they may 
play in protecting the South African black population group from the increased risk of kidney stone 
disease. 
 
1.7. Lactobacillus Genus 
Lactic acid bacteria (LAB) are microorganisms that have traditionally been used in fermented foods 
and beverages, and they are documented as generally regarded a safe (GRAS) for use in these 
foodstuffs (Klaenhammer et al., 2005). The Lactobacillus genus is a heterogeneous microbial group 
containing approximately 135 species and 27 subspecies, whose classification is constantly being 
redistributed (Bernardeau et al., 2008). They are Gram-positive, nonspore-forming, rod shape 
bacteria with no flagella, which ferment sugars to produce lactic acid. Furthermore, these lactobacilli 
are regarded as strictly fermentative, aerotolerant and acidophilic and have a GC content that ranges 
between 33 mol% and 55 mol% (Stiles and Holzapfel, 1997). There are a number of Lactobacillus 
strains that exert health-benefits on the host (Heller, 2001), which possess desirable and functional 
characteristics for use as probiotics. These include Lactobacillus gasseri, Lactobacillus acidophilus, 
Lactobacillus johnsonii among others (see section 1.7). However, the identification of Lactobacillus 
species using traditional phenotypic methods is generally difficult and unreliable because most of 
these strains have similar nutritional and physiological characteristics (Quere et al., 1997; Kao et al., 
2007). Studies have, therefore, focused on the use of molecular methods to assist in discerning 
closely related species, as they offer high sensitivity and discriminatory power for identification of 
probiotic microorganisms (Holzapfel et al., 2001).  
 
Several studies have been done on probiotic lactobacilli strains to determine their potential to 
degrade oxalate in preventing kidney stone. Campieri et al. (2001) found reduced levels of oxaluria 
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in patients with calcium-oxalate urinary stone disease and mild hyperoxaluria who were treated with 
an oral mixture of freeze-dried oxalate degrading lactic acid bacteria. Turroni et al. (2007) evaluated 
the oxalate degrading activity in several Lactobacillus species used as probiotics and showed that 
this was high. This demonstrated that Lactobacillus species could possibly be used in a probiotic 
approach for treatment of kidney stone disease. 
 
1.8. Mechanism of oxalate metabolism in Lactobacillus species 
Campieri et al. (2001) investigated the presence of homologues of the O. formigenes oxlT, oxc and 
frc genes in Lactobacillus species by PCR amplification of genomic DNA using gene specific 
primers. No amplification products were observed, indicating that they had failed to detect the genes 
under the PCR conditions used. However, in the recent studies, Turroni et al. (2007) used different 
primers and PCR conditions and reported the presence of oxc and frc genes in Lactobacillus strains. 
The oxc and frc genes encoding oxalyl-CoA decarboxylase and formly-CoA transferase respectively 
were also identified in L. acidophilus NCFM by Azcarate-Peril et al. (2006). Transcriptional analysis 
revealed that mildly acidic conditions were a prerequisite for transcription of these genes. This was 
further confirmed by Lewanika et al. (2007), who reported that these genes were regulated under 
mildly acidic conditions in Lactobacillus gasseri Gasser AM63T. 
  
1.9. Lactobacillus species as probiotics 
Probiotics are defined as live microorganisms, that when ingested, provide a health benefit on the 
host (Reid et al., 2003) and hence they promote intestinal microbial balance. LAB species are 
frequently used as probiotics, especially Lactobacillus species due to its beneficial properties and the 
important role it plays in maintaining the intestinal environment and in stimulating the immune 
system of the host (Reid, 1999). For these bacteria to be considered as probiotics, there are several 
10 
 
aspects to be studied. These include their response to antibiotics (sensitivity or resistance), their 
ability to inhibit pathogenic bacteria, adhesion to the host tissue, tolerance to gastric transit, and bile 
salts tolerance (Charteris et al., 1998a; Rönkä et al., 2003). These aspects are reviewed in detail 
below. 
 
1.9.1. Antibiotic susceptibility 
The ecological balance of the intestinal microbiota is essential for the health of the host and helps to 
prevent colonisation by pathogenic microorganisms (D’Aimmo et al., 2007). Antibiotics have 
traditionally been used in the treatment of microbial diseases (Mathur and Singh, 2005). However, 
the intake of antibiotics may interfere with the microbial balance of human microbiota (Rafii et al., 
2008). For instance, it may lead to the increase of antibiotic-resistant microorganisms due to either 
misuse or excessive use of antibiotics (Mathur and Singh, 2005). This would be detrimental to 
human health since resistance would prevent the functionality of antibiotics in treating infections 
(Sullivan et al., 2001). Bacterial resistance to antibiotics can be either be intrinsic or acquired. 
Intrinsic resistance is defined as a naturally occurring feature which is present in all strains of a 
particular species or genus. Acquired resistance may be caused by genetic mutation or acquisition of 
foreign material (DNA) from other bacteria through plasmid or transfer of genomic DNA (Saarela et 
al., 2000; Courvalin, 2006). Probiotics that are resistant to antibiotics may possibly be harmful to the 
human host since they may have the capacity to transfer resistance genes to pathogenic bacteria 
(Curragh and Collins, 1992). However, the advantage of probiotics that are resistant to antibiotics is 
that they could be administered during antibiotic treatment and still survive and be beneficial to 
people whose normal intestinal microbiota is low in number due to the effects of the antibiotic 
(Cebeci and Gürakan, 2003; Salminen et al., 1998). It is therefore, essential to characterise the 
antibiotic resistance capabilities of potential probiotics in order for them to be used appropriately. 
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1.9.2. Antimicrobial activity 
Lactobacillus species play a protective role in the gut by hindering the growth of pathogenic bacteria 
through the production of a variety of compounds with inhibitory activity (Piard and Desmazeaud, 
1992). The inhibitory activity is due to the production of organic acids (such as lactic acid), hydrogen 
peroxide, bacteriocins (Aroutcheva et al., 2001), reuterin (Axelsson et al., 1989) and diacetyl (Jay, 
1982). Interestingly, Annuk et al., (2003) stated that these antimicrobial compounds produced by 
LAB, have been shown to exert a specific antagonistic action against Gram-positive and Gram-
negative pathogens. For instance, Gram-positive bacteria have been shown to be particularly 
sensitive to bacteriocins (Abee et al., 1995). On the other hand, Jay (1982) showed that Gram-
negative bacteria were more affected by diacetyl produced by Lactobacillus species than Gram-
positive bacteria. There are also other mechanisms that have been proposed to be responsible for 
eradicating pathogens. These include competition for adhesion in inhibiting pathogens present in 
epithelia and mucosal surfaces, and stimulation of mucosal immunity (Servin, 2004). Therefore, the 
antagonistic properties of probiotics could be beneficial to the host in treatment of bacterial infection 
caused by possible pathogens. 
 
1.9.3. Low pH  
Acid resistance is considered as one of the desirable properties when selecting potential probiotic 
bacteria (Guo et al., 2009). The ability of probiotic bacteria to withstand an acidic environment is 
vital, especially when passing through the stomach and into the gut in order to exert beneficial 
effects on the host. Several mechanisms are available for bacteria to tolerate and shield themselves in 
a low pH environment. Gram-positive bacteria, in particular, survive acidic environments by means 
of several possible mechanisms (Fig. 1.3). Proton pumps can be used to regulate the cytoplasmic pH 
and play a crucial role in acid tolerance. Proteins involved in the repair or degradation of damaged 
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cell may be produced. The cell envelope may be altered such that the cells are protected by changing 
their architecture, composition, stability, and activity. Finally, cells may produce alkaline compounds 
to neutralize the acid environment. These mechanisms are discussed in greater depth below (Cotter 
and Hill, 2003). 
 
 
Figure 1.3. Mechanisms of resistance to low pH in Gram-positive bacteria (Cotter and Hill, 2003).  
 
Microbial resistance to low pH involves various mechanisms, but F1F0 ATPase has been shown to be 
an important component in response and tolerance of Gram-positive bacteria to low pH. The enzyme 
is involved in pumping protons from the cytoplasm to the exterior of the cell, thereby maintaining 
the internal pH within the acidic environment (Cotter and Hill, 2003). In an alternative mechanism, 
glutamate decarboxylase (GAD) is the enzyme responsible for consumption of protons this results in 
the rise of intracellular pH, thus controlling the bacterial pH environment (Cotter and Hill, 2003). 
This works together with γ-aminobutyrate (GABA) which is the product produced when glutamate is 
decarboxylated in the cytoplasm (Cotter and Hill, 2003) (Fig. 1.3).  
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Several enzymes are involved in the repair of pH-induced damage. RecA is essential for the repair of 
DNA and restarting stalled replication forks (Cotter and Hill, 2003; Cox et al., 2000). Uvr is also 
involved in DNA repair, which assists the bacterial survival at low pH (Hartke et al., 1996). DnaK is 
a member of class I heat shock proteins which participates in the protein folding and protection of 
denatured proteins (Bukau and Walker, 1989). The gene encoding DnaK is induced by acid shock, 
increasing the level of DnaK protein to maintain the proteins in the acidic environment. GroEL is 
another example of a protein that participates in protein folding, which is induced in response to acid 
stress condition (Fayet et al., 1989). The Htr protease degrades abnormal proteins produced during 
stress conditions, while the Clp ATPases function in the degradation of misfolded proteins (Cotter 
and Hill, 2003). Lo18 is another type of stress protein with a chaperone-like function that is induced 
by several stresses, including low pH (Guzzo et al., 1997). DltC is a protein that is encoded by the dlt 
operon and is involved in the synthesis and secretion of activated D-alanine (Cotter and Hill, 2003). 
Inactivation of dltC gene results in the generation of an acid-sensitive Streptococcus mutans strain, 
which shows in increased proton permeability and a failure to induce a significant acid tolerance 
response (ATR), both of which ensure survival at a low pH (Boyd et al., 2000). 
 
Diacylglycerol kinase (DagK) is an enzyme involved in phospholipid metabolism, and in 
Streptococcus mutans mutants, its deficiency has an effect on the membrane architecture and 
composition (Yamashita et al., 1993). Ffh is a type of chaperonin which participates in the 
translocation of protein and membrane biogenesis (Luirink and Dobberstein, 1994). Streptococcus 
GTP-binding protein (SGP) is a protein located in the membrane of S. mutans, which is induced 




Urease and arginine deiminase pathways are other mechanisms by means of which bacteria can 
maintain the intracellular pH. This involves the production of ammonia (NH3) which combines with 
proteins and leads to production of ammonium (NH4
+) in the cytoplasm elevating the internal pH 
(Cotter and Hill, 2003). Two component signal transduction systems and sigma factors have been 
shown to be involved in the regulation of these mechanisms by which bacteria respond to low pH 
(Cotter and Hill, 2003). Cell density has been found to influence cell-to-cell communication. 
Modification of cell envelope is also another means of defence from extremely acidic pH (Cotter and 
Hill, 2003). However, above all, F1F0 ATPase, GAD, GABA, DnaK and GroEL, arginine deiminase 
pathway have been identified in Lactobacillus species, and have been shown to contribute in the 
acid-stress response mechanism (Cotter and Hill, 2003; Lim et al., 2000). 
 
1.9.4. Bile  
The ability to tolerate bile is an important criterion that bacteria should fulfil in order to be used as 
probiotics (Charteris et al., 1998a). The presence of bile in the gut presents several challenges to 
bacteria due to its antimicrobial action. These include damage to the cell membrane and modification 
of macromolecules through DNA damage or incorrect protein folding (Begley et al., 2005). Gram-
positive bacteria are known to be more sensitive than Gram-negative bacteria to the detrimental 
effect of bile (Begley et al., 2005; Floch, 2002). 
 
Bile salts are effective detergents that promote emulsification and digestion of fats (Ridlon et al., 
2006). They are synthesised from cholesterol in the liver and are secreted as the glycine or taurine 
conjugated form into the duodenum, where they play a part in absorption of fats (Noriega et al., 
2006). Thereafter, bile salts are reabsorbed in the ileum and colon after deconjugation by intestinal 
microbiota (such as Lactobacillus species) and returned to the liver (Bron et al., 2004).  
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The deconjugation of the bile salts is carried out by bile salt hydrolases (BSH). The mechanism of 
how BSH activity contributes to the usefulness of intestinal bacteria in the gastrointestinal tract has 
not yet been entirely understood (Noriega et al., 2006). However, a review by Begley et al. (2005) 
reported that, there are several hypotheses concerning this issue. One hypothesis proposes that 
deconjugation may exert a beneficial advantage in bacteria of some species which may utilize 
liberated amino acids taurine as an electron acceptor. The second hypothesis proposed that BSH 
assists the inclusion of cholesterol or bile into the bacterial membrane. This may increase the strength 
of the membranes or alter the membrane characteristics that may affect the sensitivity of host 
defence molecules. The final hypothesis states that deconjugation may decrease the toxicity of 
conjugated bile salts, increasing the chances for the survival of bacteria in the gastrointestinal tract. 
BSH activity has been found in certain Lactobacillus species, however, the resistance to bile salts 
encountered in the intestine varies greatly between the species and strains (Erkkilä and Petäjä, 2000; 
Chateu et al., 1994) and the mechanism is not yet fully understood (Šušković et al., 2000).  
 
1.9.5. Adhesion 
The ability of microorganisms to attach to intestinal epithelial cells is regarded as one of the essential 
criteria when selecting potential probiotic bacteria (Buck et al., 2005). Adhesion plays a significant 
role in the ability of bacteria to colonize the human gut and thereby exert health-promoting effects on 
the host. Therefore, when potential probiotic bacteria are ingested they need to establish themselves 
permanently in the human gut (Zhao et al., 2007). In order to do this they should have the ability to 
adhere to the intestinal epithelium to prevent being washed away by the normal flow of human gut 
fluids (Salminen et al., 1998). There is very little information on the mechanisms through which 
intestinal microflora become established and endure in the intestine (Adlerberth et al., 1996). 
However, two mechanisms were proposed by means of which probiotic microbiota adhere to the host 
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intestinal epithelium (Charteris et al., 1998a). These are non-specific adhesion mediated by surface 
charge interactions, and specific hydrophobic interaction (receptor-specific binding) mediated by 
exocellular polysaccharide, lipotechoic acid and proteins. Some studies have, however, shown that 
adhesion in Lactobacillus species could be mediated by proteins (Conway and Kjelleberg, 1989; 
Cocconnier et al., 1992) or possibly, carbohydrates (Henriksson et al., 1991). 
 
Overall, an organism can only be considered to be a probiotic once these properties have been 
identified. The consumption of this product is aimed at promoting beneficial attributes of the host, by 
the use of microbiota that resides in the gastrointestinal tract. This requires detailed information of 
the microbiota that will be developed as a probiotic. 
 
1.10. Research objectives 
As previously discussed, many Lactobacillus species have been shown to possess beneficial 
properties, which make them ideal candidates for use as probiotics. This study aims at identifying 
new Lactobacillus strains isolated from healthy human faecal samples that have the ability to 
degrade oxalate and may possibly be useful in the development of probiotics for the treatment of 
kidney stone disease. 
 
Related work conducted at the University of Cape Town looked at the diversity of total faecal 
Lactobacillus species between a high kidney stone group risk and low risk group with the aim of 
identifying possible species involved in oxalate degradation in the gut (Magwira, 2008). Findings 
revealed that Lactobacillus species from the low risk group exhibited higher oxalate degrading 
activity as compared to those from high risk population, suggesting that Lactobacillus species may 
perhaps play a role in protecting individuals from developing kidney stones. 
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In a pilot study, four Lactobacillus strains isolated from healthy, low risk subjects seemed to show an 
increased ability to degrade oxalate. In this study, the aim was to identify these Lactobacillus strains 
to the species level with the use of molecular tools, to confirm their ability to degrade oxalate, and to 
investigate their probiotic characteristics such as antibiotic resistance, their ability to inhibit the 
growth of pathogens, their adhesion ability, and their acid and bile tolerance. The strains were also 
examined at the genetic level with respect to the regulation of genes encoding enzymes involved in 






















IDENTIFICATION OF LACTOBACILLUS ISOLATES 
 
2.0. Summary 
Four Lactobacillus strains previously isolated from healthy human fecal samples were identified 
using molecular based methods. The strains were initially identified by 16S rRNA gene sequencing 
and the identity confirmed by amplification of the 16S-23S rRNA gene spacer region. These regions 
are known to be highly conserved and discriminative. A phylogenetic tree was also constructed to 
understand the relationships between the Lactobacillus strains as compared with reference strains 
from the current Lactobacillus taxonomy group. The resulting identity of the strains were as follows; 

























The four bacterial isolates used in this study were, in a previous study (Magwira, 2008) putatively 
identified as members of the genus Lactobacillus. A detailed identification was, therefore, necessary 
to enable their development as possible probiotic strains. Lactobacillus has traditionally been 
identified based on cell and colony morphology, as well as biochemical tests (Zhong et al., 1998). 
However, these phenotypic methods have been shown to be disadvantageous due to the fact that, 
they are labour-intensive and may be inaccurate because of the related nutritional and growth needs 
of many different Lactobacillus species (O’Sullivan, 2000; Kao et al., 2007).  
 
Studies have, therefore, shifted towards using molecular-based methods, which have been used by 
several authors in the identification of Lactobacillus species and to understand the phylogenetic 
relationships among species (Zhong et al., 1998; Olsen and Woese, 1993). These methods include; 
16S rRNA gene sequencing (Morotomi et al., 2002), 16S-23S rRNA intergenic region sequencing 
(Tannock et al., 1999), randomly amplified polymorphic DNA (RAPD)-PCR (Tilsala-Timisjärvi and 
Alatossava, 1998), pulsed field gel electrophoresis (PFGE) (Roy et al., 1999) and DNA-DNA 
hybridization (Schillinger, 1999). Such methods have been shown to be consistent, reproducible and 
efficient enough to discriminate between closely related species (Singh et al., 2009). RAPD analysis 
is a PCR-based technique that helps to distinguish between closely related bacteria with the use of 
short arbitrary primers that will randomly bind to the genomic DNA of microorganisms to produce a 
DNA fingerprint (Tilsala-Timisjärvi and Alatossava, 1998; Welsh and McClelland, 1990). PGFE is a 
technique based on the use of genomic DNA digested with restriction enzymes, separated into large 
DNA fragments to distinguish among closely related Lactobacillus species (Tynkkynen et al., 1998). 
The DNA-DNA hybridization method determines the similarity between two DNA samples and can 
show the taxonomic relationship between closely related species (Kwon et al., 2004)  
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In this study, the use of 16S rRNA and 16S-23S rRNA gene spacer region sequencing was applied to 
identify the 4 Lactobacillus isolates, because they are regarded as sufficiently sensitive to 
discriminate between closely related species.  
 
Ribosomes are composed of protein and RNA moieties and are regarded as essential components of 
prokayortic and eurkaryotic cells (Barry et al., 1991). In prokaryotes, the rRNA genetic loci consist 
of conserved genes (16S, 23S and 5S rRNA genes) that are located within an operon on the bacterial 
chromosome and separated by spacer regions (Jensen et al., 1993; Tannock, 1999) (Fig. 2.1). 
 
Figure 2.1. The rRNA operon of bacteria showing the 16S-23S rRNA gene spacer region. P1P2 = promoters; 
T1T2 = terminators (Tannock, 1999). 
 
Sequence analysis of the 16S rRNA gene is known to be an accurate and useful technique that has 
been used widely to study the phylogenetic, inter and intragenic relationships among multiple genera 
(Leblond-Bourget et al., 1996; O’Sullivan, 2000). Because it is highly conserved, the 16S rRNA 
gene is known to possess a similar length (approximately 1.5 kb) throughout the entire bacterial 
kingdom (Gürtler and Stanisich, 1996). However, as the evolutionary distance between bacteria 
decreases, differences in the 16S rRNA gene sequences has been shown to be insufficient in 
discriminating between closely related species (Leblond-Bourget et al., 1996). Other studies have 
used the 23S rRNA genes sequence for bacterial identification, but because of its large size (3 kb), it 
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is a less useful gene to target (Berthier and Ehrlich, 1998). Moreover, neither the 23S nor 5S rRNA 
gene sequences have been extensively used for phylogenetic studies. 
 
The 16S-23S rRNA gene spacer region, however, has been regarded as a more accurate tool in 
bacterial identification because of the polymorphisms between closely related species (Gürtler and 
Stanisich, 1996). These polymorphisms within the spacer region can be due to the number and type 
of tRNA sequences that occur there. For instance, the majority of Gram-negative bacteria contain 
tRNAAla and tRNAile genes, whereas others may contain only tRNAGlu (Osorio et al., 2005). 
However, in the case of Gram-positive bacteria, the spacer region may contain either tRNAAla or 
tRNAile or both of the genes (Nour, 1998). The 16S-23S rRNA gene spacer region is commonly 
amplified by carrying out a PCR, using primers from highly conserved flanking sequences (Jensen et 
al., 1993), thereby discriminating between closely related species. 
 
The aim of this study was to identify the four putative Lactobacillus isolates to the species level, and 
to establish a phylogenetic tree of the isolates to show their relationship to other Lactobacillus 
species by analysing the sequences of their 16S rRNA genes and 16S-23S rRNA gene spacer 
regions. 
 
2.2. Materials and methods 
2.2.1. Strains, media and growth conditions 
The following putative Lactobacillus strains isolated from human faecal samples were used in this 
study: B7(3), B17(4), B17(7) and B16(9). They were stored at -70°C in de Man Rogosa Sharpe 
(MRS) broth (Biolab) with 50% glycerol. Cultures were grown anaerobically in MRS medium at 
37°C and subcultured twice in MRS before use. Escherichia coli was grown aerobically in Luria-
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Bertani medium (LB). The anaerobic cultivation was carried out in an anaerobic chamber (Forma 
Scientific, model 1024) in an atomosphere consisting of 5% hydrogen, 10% carbon dioxide and 85% 
nitrogen. 
  
2.2.2. Isolation of genomic DNA from the bacterial isolates 
The Lactobacillus isolates were streaked on MRS agar and incubated anaerobically for 48 h. Single 
colonies were then inoculated into 5 ml MRS broth and incubated anaerobically at 37oC for 18 h. 
This culture (2 ml) was centrifuged at 14.000 rpm for 2 mins, to collect the cells. The pellet was 
resuspended in 200 µl of lysis buffer (20 mM Tris-Cl [pH 8.0], 2 mM EDTA, 1.2% Triton, and 20 
mg/ml lysozyme) and incubated for 30 mins. Proteinase K (2 µl) was added and the mixture was 
incubated for another 30 mins. The genomic DNA extraction was carried out with the Genomic DNA 
Purification Kit (Fermentas Life Science) according to the instruction manual, with 10 µg/ml of 
RNAse treatment prior to the precipitation step.The genomic DNA was eluted with 30 µl of sterile 
distilled water and stored at -20oC. The DNA quality and concentration was determined by agarose 
gel electrophoresis and spectrophotometric measurement using a NanoDrop® ND-1000 
spectrophotometer (Nanodrop Technologies). 
 
2.2.3. 16S rRNA gene PCR 
The 16S rRNA gene was amplified in a 50 µl PCR reaction, containing 200 ng of genomic DNA, 2.5 
µl of the universal primers F27 (F) and R5 (R) at 10 µM (Table 2.1), 25 µl of Kapa Ready Mix 
(Kapa Biosystems) and 18 µl of sterile distilled water. As a negative control, PCR was performed 
using water instead of DNA, and for positive control, DNA from Lactobacillus plantarum KLDS 
1.0728 was used. The amplification was performed using a thermocycler (GeneAmp® PCR system 
9700, Applied Biosystems) under the following conditions: pre-denaturation at 96oC for 2 mins, 
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followed by 25 cycles of denaturation at 95oC for 30 sec, annealing temperature of 55oC for 30 sec, 
elongation temperature at 72oC for 1 min and final elongation at 72oC for 3 mins. The PCR products 
were separated by electrophoresis on an 0.8% agarose gel containing ethidium bromide. The PCR 
products were purified using the Biospin PCR purification kit (BioFlux) and then sequenced.  
 
Table 2.1. Description of primers used in this study 
Name  Primer sequences (5′-3′) PCR Fragment size (bp) References 
F27  (F) 
R5   (R)   16S rRNA 
AGAGTTTGATCCTGGCTCAG 
ACGGITACCTTGTTACGACTT 
1500 Lane, 1991 
Alm et al., 
1996 
16A  (F) 
23B  (R)   16S-23S rRNA 
GAATCGCTAGTAATCG 
GGGTTCCCCCATTCGGA 




2.2.4. 16S-23S rRNA spacer region PCR 
For the amplification of 16S-23S rRNA spacer region, the PCR mixture (50 µl) consisted of 200 ng 
of genomic DNA, 2.5 µl of 16A (F) and 23B (R) primers at 10 µM (Table 2.1), 25 µl of Kapa Ready 
Mix (Kapa Biosystems) and 18 µl of sterile distilled water. Amplification was performed using a 
thermocycler (GeneAmp® PCR system 9700, Applied Biosystems) with initial denaturation at 94oC 
for 5 mins, followed by 30 cycles of denaturation at 94oC for 30 sec, annealing at 53.5oC for 30 sec 
and elongation at 72oC for 30 sec, with a final elongation at 72oC for 5 mins. The PCR products were 
visualised on a 2% agarose gel stained with ethidium bromide. Three bands were observed on the 
gel, and the smallest band (400 bp) was excised from the agarose gel with a sterile blade and 
extracted with the BioSpin gel extraction kit (BioFlux). This DNA was used as a template in a 
second round of PCR. The amplified PCR product was purified again and cloned into Escherichia 
coli DH5α competent cells (Sambrook et al., 1989), using the pTZ57R/T vector (Fermentas Life 
Science), following the protocol provided by InsTAclone PCR Cloning Kit (Fermentas Life 
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Science). The transformants were screened on LB agar plates containing 250 µg/ml ampicillin, 500 
µg/ml X-Gal and 0.25 mM IPTG. The white colonies were isolated and screened to confirm the 
presence of inserts using colony PCR (Sambrook et al., 1989). Three positive clones were picked and 
each clone was grown in 5 ml LB medium with 5 µl of ampicillin, the plasmid DNA extracted using 
the peqGOLD Plasmid Miniprep Kit I (peQLab Biotechnologie GmbH) and the inserts were 
sequenced. 
 
2.2.5. DNA sequencing and phylogenetic analysis  
The nucleotide sequencing was carried out using the fluorescent dideoxynucleotide chain termination 
method (Sanger et al., 1977) and the MegaBACE 500 DNA sequencer (Amersham Pharmacia 
Biotech, Buckinghamshire, UK). The nucleotide sequence obtained was analysed and edited using 
the DNAMAN program package (Lynnon Corporation, Quebec, Canada) and further analysed on-
line using the BLAST server at the NCBI sequence database (http://www.ncbi.nlm.nih.gov). A 
similarity of > 98% to the 16S rRNA gene or 16S-23S rRNA gene spacer region sequences of the 
strains was used as the standard for the identification. Nucleotide sequence alignments were 
performed using the ClustalW program (Thompson et al., 1994). The phylogenetic trees were 
constructed using the program MEGA 4.0 (Tamura et al., 2007). The bootstrap test of Phylogeny-
Neighbor Joining Tree option with 1000 iterations was used to produce phylogenetic trees.  
 
2.3. Results and Discussions 
2.3.1. 16S rRNA 
The 16S rRNA gene of the putative Lactobacillus isolates was amplified using F27 (F) and R5 (R) 
primers (Table 2.1). All the isolates produced a single PCR product of approximately 1500 base pairs 
(Fig. 2.2). The positive control (Lane 5) produced the expected product size, confirming the sizes of 
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the 4 Lactobacillus strains. No amplification product was observed in the negative control (Lane C), 
indicating the absence of contaminating DNA. 
 
Figure 2.2. Agarose gel electrophoresis of PCR products of the 16S rRNA gene from Lactobacillus isolates. 
Lane MW, Molecular size marker (λ DNA digested with PstI); 1, B7(3); 2, B17(4); 3, B17(7); 4, B (16)9; 5, 
Positive control (L. plantarum KLDS 1.0728); C-: Negative control. 
 
DNA sequencing of 16S rRNA gene PCR products revealed the identity of the isolates (Table 2.2). 
Isolates B7(3) and B17(4) had 100% identity to L. gasseri NCC2857 (FJ557005.1), a novel 
Lactobacillus spp. isolated in Spain. The two isolates may be identical to each other, although they 
were isolated from different individuals, denoted by B7 and B17. Isolate B17(7) showed 99% 
identity to L. reuteri LU3 (AY735406.1), isolated from food from Korea and B16(9) showed 98% 
identity to L. vaginalis DoxG3 (GQ422709.1) isolated from dental plaque. 
 
Table 2.2. Percentage identity of the Lactobacillus isolates using 16S rRNA gene sequence analysis. 
Isolate Close relative Accession number % Identity 
B7(3) L. gasseri NCC2857 FJ557005.1 100 
B17(4) L. gasseri NCC2857 FJ557005.1 100 
B17(7) L. reuteri LU3 AY735406.1 99 




A 16S rRNA based phylogenetic tree was constructed with the Phylogeny program (MEGA 4.0 
version). This analysis is essential as it provides information regarding the relationship of the strains 
with reference strains (Olsen et al., 1994). The phylogenetic relationship was observed between the 4 
Lactobacillus isolates in comparison with other Lactobacillus species (Fig. 2.3). 
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Figure 2.3. Phylogenetic tree based on the 16S rRNA gene sequences demonstrating the relationship of the 
Lactobacillus isolates in comparison with other Lactobacillus species. The GenBank accession numbers of the 
used 16S rRNA gene sequences of the Lactobacillus species are in paranthesis. Numbers at each branch-point 
represent the bootstrap values. This figure was generated using Mega 4.0 (Tamura et al., 2007). 
 
Isolates B7(3) and B17(4), clustered together with the L. gasseri NCC2857 strain (FJ557005.1), 
demonstrating a close relationship between the three Lactobacillus strains. However, these two 
isolates were shown to be clearly distinct from B17(7) and B16(9) isolates, as they clustered in 
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different branches. The B17(7) isolate was shown to be closely related to L. reuteri LU3 
(AY735406.1), whereas the B16(9) isolate matched closely to L. vaginalis DoxG3 (GQ422709.1). It 
is important to note that the genus Lactobacillus consists of several groups composed of species that 
have been defined based on their 16S rRNA gene sequences. These include the L. acidophilus group 
(L. johnsonii, L. gasseri, L. acidophilus and L. jensenii), the L. casei group (L. rhamnosus, L. sakei 
subspecies and L. curvatus), the L. plantarum group (L. plantarum and L. paraplantarum), the L. 
buchneri group (L. brevis, L. bruchneri and L. spicheri) the L. salivarius group (L. salivarius and L. 
animalis) and the L. reuteri group (L. vaginalis, L. fermentum, L. frumenti and L. reuteri) (Canchaya 
et al., 2006). Since the L. reuteri group clearly demonstrates that L. vaginalis and L. reuteri are 
closely related, this may explain the phylogenetic relationship seen between the B17(7) and B16(9) 
isolates. However, studies have reported that, 16S rRNA gene sequencing may not always 
considered to be the best approach for classifying, due to the high similarity in this gene among 
closely related species in the various Lactobacillus groups (Kao et al., 2007). Amplification of 16S-
23S rRNA spacer region can however, provide better identification of closely related species.  
 
2.3.2. 16S-23S rRNA spacer region 
As explained previously, the amplification of 16S-23S rRNA spacer region is known to be more 
discriminatory than the amplification of 16S rRNA gene. Therefore, the putative Lactobacillus 
isolates were further examined by amplifying the 16S-23S rRNA spacer region, using the 16A (F) 
and 23B (R) primers (Table 2.1) to determine their identity. The PCR products yielded 3 main bands 
(Fig. 2.4). Interestingly, the banding pattern for lane 1 and 2 differed marginally from that of lane 3 
and 4, in that the band sizes varied. This demonstrated that there are differences among the isolates. 
It should be noted that a typical pattern of Lactobacillus strain consist of 3 bands, the small, medium 
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and large spacer region, as reported by Moreira et al. (2005). Moreover, the variation in these lengths 
could be due to either the number or type of tRNA sequences present in this region. 
 
Figure 2.4. Agarose gel electrophoresis of PCR of the 16S-23S rRNA spacer region from 4 Lactobacillus 
isolates. Lane MW: Molecular size marker (λ DNA digested with PstI); 1, B7(3); 2, B17(4); 3,B17(7); 4, B 
(16); C-, Negative control. 
 
The small (400 bp) bands of the Lactobacillus isolates were excised and cloned into the pTZ57R/T 
vector as previously described. The inserts were confirmed and sequenced. The nucleotide sequences 
obtained were analysed, aligned and a phylogenetic tree was constructed. The sequences revealed by 
BLAST analysis confirmed that isolates B7(3) and B17(4) had a 99% identity with L. gasseri ATCC 
33323 (CP000413.1) (Table 2.3). B17(7) displayed 100% identity with L. reuteri DSM 20016 







Table 2.3. Percentage identity of the Lactobacillus isolates using 16S-23S rRNA gene spacer region sequence 
analysis. 
Isolate Close relative Accession number % Identity 
B7(3) L. gasseri ATCC 33323  CP000413.1 99 
B17(4) L. gasseri ATCC 33323  CP000413.1 99 
B17(7) L. reuteri DSM 20016  CP000705.1 100 
B16(9) L. reuteri JCM 1112  AP007281.1 100 
 
The phylogenetic tree was constructed to determine the phylogenetic relationship among the 
Lactobacillus isolates in comparison with the reference Lactobacillus species (Fig. 2.5).  
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Figure 2.5. Phylogenetic tree based on the 16S-23S spacer region sequences demonstrating the relationship of 
the putative Lactobacillus isolates in comparison with other Lactobacillus species. The GenBank accession 
numbers of the used 16S-23S rRNA spacer region sequences of the Lactobacillus species are in paranthesis. 
Numbers at each branch-point represent the bootstrap values. 
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The B7(3) and B17(4) isolates consistently clustered together and were closely related to the L. 
gasseri ATCC 33323 strain (CP000413.1). The two isolates also clustered with L. acidophilus and L. 
johnsonii strains, suggesting that the strains may also be closely related. The B17(7) and B16(9) 
isolates clustered with L. reuteri strain DSM 20016 (CP000705.1) and L. reuteri JCM 1112 
(AP007281.1) as expected demonstrating a very close relationship. Using the 16S rRNA gene 
sequence, the B16(9) isolate was identified as L. vaginalis, however, using the 16S-23S rRNA spacer 
region sequence, it was identified as L. reuteri. This could possibly be due to the fact that the 16S-
23S rRNA gene spacer region is more accurate in discriminating closely related species (Gürtler and 
Stanisich, 1996). Taking the 16S rRNA gene sequence and 16S-23S rRNA spacer region sequence 
data together, the 4 putative Lactobacillus strains were identified as L. gasseri 7(3), L. gasseri 17(4), 
L. reuteri 17(7) and L. reuteri 16(9). 
 
As explained previously, the genus Lactobacillus represents a variety of species, which have been 
isolated from several habitats, such as the gastrointestinal tract of animals and humans, oral and 
genital tracts (Roos et al., 2000). However, among this genus, certain Lactobacillus species are 
recognised as truly autochthonous (natural) gut inhabitants, such as L. salivarius, L. reuteri, and L. 
gasseri, while others species such as L. plantarum and L. brevis are considered as transient 
(allochthonous) gut inhabitants of the host (Dal Bello et al., 2003). This study revealed the identity 
of the Lactobacillus isolates, L. gasseri 7(3), L. gasseri 17(4), L. reuteri 17(7) and L. reuteri 16(9), 
indicating that these strains could be referred as autochthonous strains, due to the fact that they are 
natural isolates. Molecular analysis has demonstrated that individual humans usually differ in their 
microflora (Kimura et al., 1997). Nonetheless, in this study the strains isolated from 4 different 
individuals were closely related. This could be due to either consumption of similar diet or 
geographic location.  
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Previous studies have been reported that the human intestinal microflora compromises of several 
microbial species that are commonly detected in the human faeces. However, among the microbial 
species, L. gasseri and L. reuteri strains have been shown to be one of the predominant Lactobacillus 
species in the human gastrointestinal tract of neonates (Wall et al., 2007) and adults (Reuter, 2000), 
the oral cavity (Munson et al., 2004), the vaginal tract (Pavlova et al., 2002), the small intestine of a 
pig (Wadström et al., 1987), human faeces, (Tannock et al., 1999), and the gastrointestinal tract and 
faeces of mouse (Hata et al., 2007). These strains have previously been demonstrated to have health-
promoting effects and are used as probiotics, which when ingested, exert positive effect on the host. 
Health benefits attributed to the consumption of L. gasseri include, boosting the immune system of 
healthy humans (L. gasseri CECT 5714) (Olivares et al., 2006), assisting in suppressing 
Helicobacter pylori infection and reducing gastric mucosal inflammation (L. gasseri OLL 2716) 
(Sakamoto et al., 2001). L. reuteri, has been shown to improve human gastrointestinal health by 
reducing the incidence and severity of diarrhoea (L. reuteri ATCC 55730) (Valeur et al., 2004; 
Shornikova et al., 1997) and may also prevent infection caused by Cryptosporidium parvum in 
immunodeficient individuals (Alak et al., 1997). Other studies have recently reported that, to 
understand the impact of gut microflora on human health and well-being, it is important to assess the 
content, diversity and functioning of the microbial gut community (Qin et al., 2010). 
 
2.4. Conclusion 
This study revealed the identity of the 4 Lactobacillus isolates based on 16S rRNA gene sequencing 
as well as the sequence of the 16S-23S rRNA spacer region. The methodology based on targeting the 
conserved ribosomal gene has been shown to be accurate in identifying and discriminately closely 
related species. However, Tilsala-Timisjärvi and Alatossava (1998) indicated that these regions are 
not sensitive enough to differentiate bacteria below the species level. Therefore, in order to validate 
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and extend the results obtained from the 16S rRNA gene and 16S-23S rRNA spacer region, it would 
have been interesting to apply other molecular tools such as RAPD and PGFE techniques. However, 
due to time-constraints, the experiments could not be performed in this study. These methods have 
been used for better discrimination of Lactobacillus strains, on the basis of their genomic profiles 
(Lortal et al., 1997; Roy et al, 1999). DNA-DNA hybridization is another technique that helps to 
distinguish closely related species at their genomic level. It determines the genetic similarity by 
measuring the degree of overall nucleotide difference between two pools of DNA (Ruvolo and 
Smith, 1986). Future work should include applying these techniques for further identification of the 4 
Lacobacillus isolates used in this study. 
Due to their potential health-promoting effects and the fact that they were isolated from their natural 
ecological environment, it was of interest to determine whether the 4 Lactobacillus strains used in 
this study had appropriate probiotic characteristics. It was also especially important to determine 
their ability to degrade oxalate in the context of their possible use in the prevention of kidney stone 















CHARACTERIZATION OF POTENTIAL PROBIOTIC STRAINS 
 
3.0. Summary 
The four Lactobacillus strains were examined for their potential as probiotics by measuring their 
antibiotic resistance, antimicrobial activity, adhesion capacity, and acid and bile tolerance. They 
were also tested to determine their oxalate degrading activity. The Lactobacillus strains were shown 
to comply with most of the criteria required to be classified as probiotics. The strains were most 
sensitive to penicillin and highly resistant to kanamycin. They demonstrated good antimicrobial 
activity against pathogenic bacteria, with high antimicrobial activity against Escherichia coli, 
Salmonella typhimurium and Staphylococcus aureus. They also displayed good adhesion properties, 
as determined by yeast agglutination and autoaggregation assays. L. reuteri 17(7) possessed the best 
adhesion properties as compared to the other strains. The strains were also tested for their oxalate 
degrading ability and L. gasseri 7(3) displayed the highest oxalate degrading activity, of more than 
30%. Among the Lactobacillus strains, L. gasseri 7(3) and L. reuteri 17(7) were selected to test their 
acid (pH 2 and pH 4) and bile (0.5% and 1%) tolerance. These strains were sensitive at pH 2, but 
tolerated pH 4 conditions well. Furthermore, these strains were shown to tolerate high bile salt 
concentrations well, with L. reuteri 17(7) able to grow as well as the control culture at 1% bile 









There are numerous microorganisms that have either been used or identified for use as potential 
probiotics (Rolfe, 2000). Amongst these microorganisms, Lactobacillus and Bifidobacterium species 
are the common bacteria traditionally used as probiotics, since they exert beneficial effects on the 
host (Rolfe, 2000). For probiotic bacteria to do this, they need to meet several criteria. These include 
appropriate resistance to antibiotic treatment, the ability to inhibit the growth of pathogenic bacteria 
by producing antimicrobial substances, efficient adhesion to the host tissue, tolerance of low pH 
during gastric transit, and tolerance of bile salts found in the gut (Charteris et al., 1998a; Rönkä et 
al., 2003). In the current study, the ability to degrade oxalate to reduce risk of kidney stone disease 
was also of interest (Azcarate-Peril et al., 2006). The possible scientific approaches that have been 
used to evaluate these features are reviewed below. 
 
3.1.1. Antibiotic susceptibility 
It is important to ascertain the antibiotic resistance or susceptibility of the strains of interest, because 
this may have an advantageous or disadvantageous effect. For example, probiotic bacteria that are 
resistant to antibiotics could possibly be given during antibiotic treatment of a disease (Vanderhoof 
et al., 1999). However, it should be noted that resistance could also be problematic, since the 
resistance determinants may be transferred to a pathogen with detrimental outcome for the host 
(Curragh and Collins, 1992). Conversely, when a probiotic bacterium is sensitive to antibiotics, it 
could be unfavourable, as it may not have a significant protecting effect in patients that are under 
antibiotic treatment (Gould and Short, 2008). Safety assessments should, therefore, be performed to 




There are several methods that have been used to determine the antibiotic susceptibility of 
Lactobacillus species. These include: Agar disk diffusion (Zhou et al., 2005; Temmerman et al., 
2003), the use of E-test strips, (Danielsen and Wind, 2003; Katla et al., 2001), broth dilution 
(Mayrhofer et al., 2008) and agar dilution (King and Philips, 2001). However, comparing the results 
obtained by these methods can be problematic, because certain methods have their own limitations. 
For instance, certain techniques have been shown to be unreliable for particular antibiotics tested, or 
the culture medium used might affect the outcome of the antibiotic susceptibility testing (Ammor et 
al., 2007). It is, therefore, important to select an appropriate method for antibiotic susceptibility 
testing. In this study, the well-described disk diffusion method was used (Zhou et al., 2005). 
 
3.1.2. Antimicrobial activity 
Lactic acid bacteria (LAB) play a protective role through hindering the growth of pathogenic bacteria 
by producing diverse inhibitory compounds (Piard and Desmazeaud, 1992). Several reports have 
described different techniques that may be used to detect the antimicrobial activity of probiotic 
bacteria, including the agar spot method, the well-diffusion technique, and the microtiter well 
method (Jacobsen et al., 1999; Dimitonova et al., 2007; Maragkoudakis et al., 2006). However, the 
agar spot method has been shown to be an accurate and reliable method and it was, therefore, used in 
this study (Jacobsen et al., 1999).  
 
3.1.3. Adhesion studies 
Numerous reports have investigated the adhesion of lactobacilli to gastrointestinal tissue or epithelial 
cells. Studies have successfully used intestinal mucus and enterocyte-like Caco-2 cells to evaluate 
the adhesion ability of probiotic bacteria (Ouwehand et al., 1999; Buck et al., 2005). However, 
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alternative in vitro methods linked to adhesion have also been described, such as determining the 
ability of the probiotic cells to agglutinate yeast as well as their efficiency of autoaggregation.  
 
Adlerberth et al. (1996) found that certain Lactobacillus plantarum strains have been shown to 
adhere specifically to mannose-containing polysaccharides in human colonic cell lines. These 
authors concluded that this characteristic may provide an advantage in adhesion which may 
potentially be involved in the ability of the bacteria to colonize the intestine. The yeast agglutination 
method, therefore, is based on studying the capacity of bacteria to adhere to mannose residues found 
on the cell wall of Saccharomyces cerevisae (Adlerberth et al., 1996). The addition of mannose-
adhering bacteria to yeast cells results in the agglutination of the yeast, which can be observed by 
light microscopy (Pretzer et al., 2005). Studies have shown that carbohydrate binding lectins and 
protein moieties on bacterial surface mediate Lactobacillus adhesion (Henriksson and Conway, 
1992; Conway and Kjelleberg, 1989; Cocconnier et al., 1992). Further studies have shown that 
carbohydrates such as mannose inhibit (Bar-Shavit et al., 1977) the adherence of bacteria to 
mammalian cells (Oyofo et al., 1989).  
 
The ability of probiotic strains to autoaggregate is another important property linked to adhesion to 
the intestinal epithelium. Their coaggregation ability with pathogens on the other hand, allows them 
to form a barrier which assists in preventing colonization of epithelium by the pathogenic bacteria 
(Kos et al., 2003; Del Re et al., 2000). Reniero et al. (1992) did a study to identify possible 
extracellular factor(s) in the culture supernatant responsible for mediating cell aggregation. The 
results indicated that the aggregation mechanism usually involved the interaction of bacterial cell 
surface components such as protein, lipoteichoic acids, and carbohydrates as mediators of adherence 
(Reniero et al., 1992; Gusils et al., 2002).  
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3.1.4. Oxalate-degrading ability 
In this study, the ability to degrade oxalate is another essential requirement for the probiotic bacteria 
under investigation, since it would allow them to prevent the development of pathological disorders 
such as hyperoxaluria (excess urinary oxalate), and kidney stone formation (Azcarate-Peril et al., 
2006). There are numerous methods available that can be used to determine oxalate degradation by 
bacteria. These include the measurement of oxalate levels by gas-liquid chromatography, ion 
chromatography, high performance liquid chromatography, mass spectrometry and enzymatic assays 
(Çalişkan, 2000). In this study, the enzymatic assay was used due to its simplicity, rapidity and 
reproducibility (Liu et al., 2009). This assay is commonly used for measurement of urinary oxalate to 
evaluate the possibility of recurrent stone formation in patients with nephrolithiasis (kidney stone 
disease).  
 
3.1.5. Low pH and bile tolerance 
The survival capacity of probiotic bacteria in the gut depends on their ability to tolerate low pH 
during gastric transit (Pennacchia et al., 2003). Several authors have used hydrochloric acid (HCl), 
acetic acid (CH3COOH) or sodium hydroxide (NaOH) to adjust the pH medium of the growth in 
order to investigate acid resistance of bacteria (Gupta et al., 1996; du Toit et al., 1998 and Delgado et 
al., 2007). Studies are generally carried out in microwell plates or universal bottles with MRS broth 
adjusted to a range of pH values. Tolerance to bile is one of the factors that determine the survival of 
the bacteria in the gut. Several bile preparations have been used to evaluate the bile resistance of 
probiotic bacteria. These include Oxgall (derived from bovine bile) cholic acid and taurocholic acid 





3.2. Materials and Methods 
3.2.1. Antibiotic susceptibility testing  
The antibiotic susceptibility of the Lactobacillus strains was determined on MRS agar (Biolab) using 
the antibiotic disk diffusion method. It was done according to Zhou et al. (2005) except that the 
bacterial strains were initially grown for 18 h at 37oC in 5 ml MRS broth under anaerobic conditions. 
The optical density (OD600) of the cell cultures was adjusted to 0.2 and 100 µl of the culture was 
spread on the MRS agar. Disks (Oxoid) impregnated with their specific antibiotics: rifampicin (5 
µg), chloramphenicol (30 µg), streptomycin (10 µg), ampicillin (10 µg), vancomycin, (30 µg) 
cephalothin (30 µg), kanamycin (30 µg), erythromycin (30 µg), penicillin G (10 µg) and tetracycline 
(30 µg), were placed aseptically on the MRS agar surface. After 48 h anaerobic incubation at 37oC, 
the diameter of the zones of inhibition was measured (mm). The experiment was done in biological 
triplicates with two technical repeats. 
 
3.2.2. Antimicrobial activity assay 
 
The antimicrobial activity of the Lactobacillus strains against 7 pathogens was evaluated using the 
agar spot method as described by Jacobsen et al. (1999), except that 5 µl of the Lactobacillus test 
culture (grown for 18 h in MRS broth) was spotted on an MRS agar plate and incubated for 48 h 
under anaerobic conditions. The pathogens tested were Escherichia coli ATCC 25922, 
Staphylococcus aureus, Salmonella typhimurium, grown in Luria medium (McCaffrey et al., 1992) 
under aerobic conditions, and Enterococcus faecium, Enterococcus faecalis, Clostridium perfrigens 
and Clostridium botulinum, grown anaerobically in Brain heart infusion medium (BHI). All these 
were pre-grown for 18 h and incubated at 37oC. The MRS agar preinoculated with the Lactobacillus 
test culture was overlaid with soft agar (0.8%) inoculated with the pathogenic bacteria. Thereafter, 
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the plates were examined for zones of inhibiton. The experiment was performed as biological 
triplicates and two technical replicates. 
 
3.2.3. Adhesion assay 
The ability of Lactobacillus strains to agglutinate yeast cells was evaluated as described by 
Adlerberth et al. (1996) and Pretzer et al. (2005) with the following modifications: Saccharomyces 
cerevisiae was grown for 20 h in YPD (10 g yeast extract, 20 g peptone and 20 g glucose) medium 
(Biolab) under aerobic conditions at 30oC. Yeast cells were harvested by centrifugation, washed with 
1X Phosphate buffered saline (PBS) (pH 7.4) and stained with safranin solution and resuspended in 1 
ml of PBS or D-mannose (BDH, Biochemicals Limited) solution (1M). The bacterial strains were 
grown for 18 h at 37oC in 5 ml MRS broth. Thereafter, 2 ml of each culture was centrifuged at 
10,000 × g for 10 mins. The supernatant was filter sterilized using a 0.4 micron filter, and placed in a 
sterile 2 ml Eppendorf tube. The bacterial cell pellet was resuspended in 1 ml of 1X PBS or culture 
supernatant. The bacterial suspension (20 µl) was placed on a glass slide, mixed with 20 µl safranin 
stained yeast cells resuspended in either PBS or mannose (1 M), and observed for yeast agglutination 
using a light microscope at a magnification of 40X (Leitz). Agglutination was also observed by 
mixing 20 µl of bacterial culture resuspended in culture supernatant with 20 µl safranin stained yeast 
cells. Yeast cells (20 µl) mixed with water (20 µl) was used as a control. 
 
To test the ability of the bacterial cells to autoaggregate, the cultures were prepared as for the yeast 
aggregation assay (above) except that the cell pellet was resuspended in a 2 ml of 0.85% sodium 
chloride (NaCl) solution and vortexed for a minute. The cell suspension was incubated in the 
presence or absence of 1 ml supernatant at room temperature. The autoaggregation ability was 
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observed visually for sand-like particles settling to the bottom of the tubes (Kmet and Lucchini, 
1999). The experiment was done as biological triplicates and two technical repeats. 
 
3.2.4. Oxalate-degrading ability of the Lactobacillus strains 
The strains were inoculated into ½ strength MRS broths (half w/v) supplemented with 10 mM 
ammonium oxalate which had been filter-sterilized and added after autoclaving. After 2 days of 
incubation at 37oC, 100 µl of the culture was transferred into fresh 5 ml ½ strength MRS broth with 
10 mM of ammonium oxalate and incubated for a further 2 days. The cell density was then adjusted 
to OD600 0.5 in sterile PBS buffer (pH 7.2) and 100 µl of this suspension was inoculated into 10 ml ½ 
strength MRS broth (supplemented with 10 mM ammonium oxalate) and incubated anaerobically for 
5 days at 37oC. On days, 2 and 5, 1 ml aliquots of the culture were centrifuged and the supernatant 
retained (stored at -20oC). This experiment was done in duplicate and ½ strength MRS broth with no 
added ammonium oxalate was used as the control. For the oxalate assay, the concentration of oxalate 
present in the supernatant fractions from days 2 and 5 was measured using the enzymatic assay kit 
(Trinity Biotech plc, Ireland).  
 
3.2.5. pH and Bile tolerance  
 
The pH and bile tolerance of the candidate bacteria was measured using a protocol based on the work 
of Prasad et al. (1998) except that the cultures were adjusted to an OD600 approximately 0.5 and used 
to inoculate fresh 20 ml MRS broths adjusted to pH 2 and 4 with HCl. To determine cell growth in 
the presence of bile, the 16 h culture was also adjusted to an OD560 of approximately 0.5 and used to 
inoculate fresh 20 ml MRS broth with Oxgall at concentrations of 0.5% and 1% (w/v). All the 
cultures were incubated anaerobically at 37oC, and after every hour, the optical density was 
measured using S1000 Diode Array Spectrophotometer (Labotec). Viability of the cells was 
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determined by diluting the cultures and plating on MRS agar plates at 0 and 6 h. The MRS agar 
plates were incubated at 37oC for 2 days under anaerobic conditions. The experiment was done as 
three biological experiments and two technical repeats. 
 
3.3. Results and Discussions 
 
3.3.1. Antibiotic susceptibility testing 
The antibiotic disk diffusion method was used to determine the susceptibility of the Lactobacillus 
strains against 11 antibiotics. The Lactobacillus strains were susceptible, to varying extents, to the 
following antibiotics; rifampicin, chloramphenicol, ampicillin, cephalothin, erythromycin, penicillin 
and tetracycline (Fig 3.1). All the test strains were most sensitive to penicillin, having the greatest 
zone of inhibition. Lactobacillus reuteri 17(7) and Lactobacillus reuteri 16(9) were both resistant to 
vancomycin, whereas Lactobacillus gasseri 7(3) and Lactobacillus gasseri 17(4) were both slightly 
sensitive to vancomycin. A similar trend was seen in the responses of the strains to streptomycin. All 
the test strains were resistant to kanamycin, confirming the findings of Danielsen and Wind (2003) 
who showed that a number of Lactobacillus strains were naturally resistant to kanamycin. Elkins and 
Mullis (2004) also reported that lactobacilli naturally show intrinsic kanamycin resistance and this 
could be due to membrane impermeability, which may possibly be complemented by potential efflux 










Figure 3.1. Antibiotic susceptibility of Lactobacillus strains. 
RD, Rifampicin; C, Chloramphenicol; S, Streptomycin; AMP, Ampicillin; VA, Vancomycin; KF, 
Cephalothin; K, Kanamycin; E, Erythromycin; P, Pencillin G and TE, Tetracycline. The error bars indicate the 
standard error calculated from three replicates of the data. 
 
These results were similar to a study reported by Zhou et al. (2005), who established the antibiotic 
susceptibility profiles of 7 Lactobacillus species to 18 antibiotics. These species were sensitive to 
ampicillin, cephalothin, pencillin, erythromycin, chloramphenicol, rifampicin and tetracycline. 
 
Homofermentative Lactobacillus species have been shown to be sensitive to vancomycin, while 
heterofermentative Lactobacillus species are naturally resistant to vancomycin (Ammor et al., 2007). 
The findings reported here are in agreement with the above mentioned statement, where the two L. 
gasseri strains were shown to be sensitive to vancomycin, while the two L. reuteri were resistant to 
vancomycin. L. gasseri strains are known to be homofermentative (more energy efficient than 
heterofermentative), whereas L. reuteri are heterofermentative (Morelli et al., 1998). Interestingly, 
the vancomycin-susceptibility results of L. gasseri 7(3) and L. gasseri 17(4) agree with the findings 
of Kõll et al. (2008), who used the E-test method to demonstrate that their L. gasseri strain was 
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sensitive to vancomycin. Generally, the vancomycin resistance is based in the production of cell wall 
peptidoglycan precursors, which terminates with D-Alanyl-D-lactate as a substitute of D-Ala-D-Ala. 
Thus, the modified D-ala-D-lactate does not bind vancomycin (Tykkynen et al., 1998).  
 
In this study, the Lactobacillus strains that exhibited resistance to kanamycin, streptomycin, 
vancomycin and less susceptibility to chloramphenicol, rifampicin and erythromycin could possibly 
be given to patient during treatment with these antibiotics. However, due to the concerns on safety of 
probiotics, further studies should investigate the possibility of resistance transfer from a probiotic 
strain to human bacterial pathogens. 
 
3.3.2. Antimicrobial activity 
The Lactobacillus strains were analyzed by the agar overlay method to test their ability to inhibit the 
growth of pathogens. It was found that most of the strains inhibited the pathogens tested to varying 
extents (Fig. 3.2). The Gram-negative pathogens were generally inhibited to a greater extent by the 
Lactobacillus strains than the Gram-positive pathogens. E. faecium and E. faecalis were not inhibited 
at all by L. gasseri 7(3), whereas L. gasseri 17(4) did inhibit these species. This indicates that their 
antagonistic activity was strain specific. Interestingly, the Lactobacillus strains showed a strong 
inhibition of E. coli, S. aureus and S. typhimurium. Overall, L. reuteri 17(7) and L. reuteri 16(9) 
appeared to inhibit the growth of these pathogens to a greater extent than the L. gasseri strains. This 
was possibly due to the production of reuterin (Talarico and Dobrogo, 1989), which is a low-
molecular weight, non-protein, pH-neutral and water-soluble substance produced by some strains of 
L. reuteri. Reuterin has been shown to have antibacterial, antimycotic and antiprotozal activities 





Figure 3.2. Antimicrobial activity of Lactobacillus strains against pathogens. The error bars indicate the 
standard error calculated from three replicates of the data. 
Ec, Escherichia coli; Sa, Staphyloccus aureus; St, Salmonella typhimurium; Ef, Enterococcus faecium; Efc, 
Enterococcus faecalis; Cp, Clostridium perfrigens and Cb, Clostridium botulinum. 
 
In a previous study, Jacobsen et al. (1999) reported that L. reuteri DSM 12246 showed a strong 
inhibition of all the pathogenic bacteria tested. In the present study, the Lactobacillus strains 
inhibited the growth of most pathogens tested, suggesting that these strains would possibly be helpful 
in protection from diseases or infections caused by pathogens. Future work on the nature of the 
antimicrobial agents produced by the test strains would be of interest. 
 
3.3.3. Yeast agglutination  
The colonization of bacteria on epithelial cells is regarded as an important criterion for selecting 
potential probiotic bacteria. In this experiment, a yeast agglutination assay was used to determine the 
potential adherence capacity of the candidate Lactobacillus strains. Agglutination of the cells with or 





   
Figure 3.3. Yeast agglutination of the Lactobacillus species. (A) L. gasseri 7(3); (B) L. gasseri 17(4); (C) L. 
reuteri 17(7); (D) L. reuteri 16(9); (E) negative control (i) with safranin stained yeast cells (ii) with mannose 
(iii) with culture supernatant. The experiment was done in duplicate. 
 
The negative control was prepared by resuspending the yeast cells with water. Positive agglutination 
was observed in all the strains, with L. gasseri 17(4) and L. reuteri 17(7) showing the strongest 
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agglutination irrespective of whether culture supernatant was added to the cells or not. L. gasseri 
7(3) and L. reuteri 16(9), showed weak agglutination in the absence of culture supernatant, however, 
it was enhanced by the addition of this solution. This could possibly be due to the presence of certain 
proteins moieties in the supernatant (Conway and Kjelleberg, 1989). The ability of these strains to 
display strong agglutination indicates that, they may contain surface receptors that could recognize 
host tissue receptors, thereby promoting binding to the epithelium. 
 
Table 3.1. Yeast agglutination efficiency 
Strains Cells Cells with mannose Cells and supernatant 
L. gasseri 7(3) + - ++ 
L. gasseri 17(4) ++ - ++ 
L. reuteri 17(7) ++ - ++ 
L. reuteri 16(9) + - ++ 
(-) no agglutination, (+) weak agglutination, (++) strong agglutination 
 
The assay was repeated by resuspending the cells in 1M solution of D-Mannose and no agglutination 
was observed.  This suggested that the D-mannose inhibited the adhesion of the bacterial cells to the 
yeast cells, thus verifying the role of the sugar moieties in the assay. A mannose specific adhesion 
mechanism has previously been studied by Adlerberth et al. (1996), who observed an interaction 
between L. plantarum strains with human colonic cell line HT-29. It was found that the adhesins 
could have been involved in mediating the adhesion. Pretzer et al. (2005) has, however, recently 
identified the mannose-specific adhesin (Msa; gene name, msa) of some L. plantarum strains with 
the ability to agglutinate Saccharomyces cerevisiae. It was, therefore, confirmed that the manose-
specific adhesins were likely to be involved in the interaction of L. plantarum with its host in the 




The adhesins present on the bacterial cell surface have been shown to agglutinate Saccharomyces 
cerevisiae cells, which are largely composed of mannose-containing polysaccharide (mannan) on 
their cell surface (Cawley and Ballou, 1972), this could be responsible for the excellent agglutination 




The autoaggregation ability of the bacterial strains was investigated by visual observation based on 
the rate at which they sedimented at the bottom of the tube (Fig. 3.4). 
 
The cells with strong auto-aggregation ability formed sand-like particles by settling to the bottom of 
the tube, resulting in a clear solution. The strain without auto-aggregation ability showed continued 
turbidity.  Of the strains tested, L. reuteri 17(7) showed rapid autoaggregation within 5 mins (Table 
3.2). Strains L. gasseri 7(3), L. gasseri 17(4) and L. reuteri 16(9), (Table 3.2) however, were unable 














Figure 3.4. Aggregation properties of 4 Lactobacillus strains 
 (A) L. gasseri 7(3); (B) L. gasseri 17(4); (C) L. reuteri 17(7); (D) L. reuteri 16(9). (i) with no supernatant (ii) 
with supernatant. The experiment was done in duplicate. 
 
Several reports have shown that filter-sterilized culture supernatant can contain proteins that promote 
the aggregation ability of Lactobacillus species (Reniero et al., 1992; Roos et al., 1999). When the 
experiment was repeated by resuspending the bacterial cells with their supernatant, there was no 
change or increase in their aggregation ability when measured after 2 h as compared to the results in 
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the absence of supernatant (Table 3.2). However, after incubating cells with supernatant, there was 
increased aggregation as measured at 16 h, which was annotated as (++). 
 
Table 3.2: Autoaggregation efficiency 
Visual score 
Strains Cells  
(After 2 h) 
Cells  
(After 16 h) 
Cells and supernatant 
(After 2 h) 
Cells and supernatant 
(After 16 h) 
L. gasseri 7(3) - + - ++ 
L. gasseri 17(4) - + - ++ 
L. reuteri 17(7) ++ ++ ++ ++ 
L. reuteri 16(9) - + - ++ 
(-) no aggregation, (+) aggregation, (++) rapid aggregation. 
 
 
The rate at which the bacterial cells settled to bottom of the tube was more rapid in comparison with 
cells in the absence of supernatant (Table 3.2). This suggests that there may be proteins present in the 
supernatant that could be responsible for the aggregation ability of the tested strains. Overall, L. 
reuteri 17(7) was found to be potentially the most adhesive strains, due to its high immediate auto-
aggregation ability. Although the other 3 strains auto-aggregated slowly, they still might possess 
sufficiently good auto-aggregation ability in later stages of colonization. 
 
3.3.5. Oxalate-degrading ability of Lactobacillus strains 
The identification of strains with oxalate degrading ability might be beneficial to individuals who 
suffer from kidney stone disease or related intestinal disorders, since they could potentially be used 
to reduce the levels of oxalate in the gut.  
 
The four Lactobacillus strains were tested to determine their ability to degrade ammonium oxalate 
(Fig. 3.5). The induced strains were grown in ½ strength MRS broth containing 10 mM ammonium 
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oxalate for 2 consecutive days to stimulate their cells to produce the necessary enzymes to utilize 
oxalate. Subsequently, the residual oxalate in fresh broth cultures was measured after 2 and 5 days of 
incubation using the oxalate assay kit (Trinity Biotech plc, Ireland). Half strength MRS broths were 
used in order for the strains to initially utilize alternative carbon sources to promote growth, and then 


























L. gasseri 7(3) day 2
L. gasseri 7(3) day 5
L. gasseri 17(4) day 2
L. gasseri 17(4) day 5
L. reuteri 17(7) day 2
L. reuteri 17(7) day 5
L. reuteri 16(9) day 2
L. reuteri 16(9) day 5
 
Figure 3.5. Oxalate degrading activity of the Lactobacillus strains grown in ½ strength MRS broths 
supplemented with 10 mM of ammonium oxalate. Activity expressed as a percentage of oxalate in 
uninoculated medium. The error bars indicate the standard error calculated from three biological replicates of 
the data. 
 
All the strains grew in ½ strength MRS broth supplemented with 10 mM ammonium oxalate, and 
reduced the amount of oxalate in the medium over a period of 5 days as compared to uninoculated 
culture medium. The growth of these strains in the presence of 10 mM ammonium oxalate 
demonstrated that oxalate at this concentration was not toxic to Lactobacillus species. L. gasseri 
7(3), L. gasseri 17(4) and L. reuteri 16(9) showed good oxalate degradation, reducing the oxalate 
concentration by 25-35%. L. reuteri 17(7) had lower oxalate degrading activity of approximately 
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10% degradation. Campieri et al. (2001) evaluated the in vitro oxalate degradation in Lactobacillus 
species, and L. acidophilus strain showed good oxalate degradation, whereas L. brevis and L. 
plantarum demonstrated a modest ability to degrade oxalate. In another study, Turroni et al. (2007) 
also evaluated the oxalate degrading activity of several Lactobacillus species; some strains 
demonstrated little or no degradation. This suggests that the ability of lactobacilli to degrade oxalate 
is both species and strain specific. 
 
Several methods have been proposed for the measurement of oxalate, each with its advantages and 
disadvantages. The oxalate assay used in this study is based on oxidation of oxalate catalysed by 
oxalate oxidase to form hydrogen peroxide and carbon dioxide. The hydrogen peroxide reacts with 3 
methyl-2-benzothiazolinone hydrazone and 3-(dimethylamino) benzoic acid in the presence of 
peroxidase to yield an indamine dye, which has an absorbance maximum at 590 nm. A major 
problem encountered with this assay (enzymatic assay) is the interference by substances such as 
ascorbate. However, in this study interfering substances such as ascorbate, were eliminated by 
treating the diluted sample with activated charcoal (Keevil and Thornton, 2006; Li and Madappally, 
1989).  
 
Turroni et al. (2007) and Federici et al. (2004) noted that the enzymatic method showed low 
accuracy as observed from the recovery tests wherein 90-110% or 93-107% of added oxalate was 
recovered. Nonetheless, several studies have applied this method to evaluate oxalate degradation 
activity in small or large scale (Lewanika et al., 2007; Turroni et al., 2007). In this study, the validity 
of the screening has not been found to be compromised by the error measurement of oxalate 
degrading capacity; instead 3 biological experiments with technical replicates were performed to 
produce reproducible results. This assay was, therefore, considered to be suitable to detect the 
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oxalate degrading activity of the 4 Lactobacillus strains, although the values obtained should not be 
compared to studies by other authors, using different conditions.    
 
3.3.6. Effect of pH on bacterial growth and viability 
Two Lactobacillus strains were selected for further investigation of their ability to withstand the 
harsh conditions of certain regions of the gut, by exposing them to low pH. L. gasseri 7(3) was 
selected for further study because it was the most efficient degrader of oxalate (Fig. 3.5), while L. 
reuteri 17(7) was also examined because despite its slightly lower oxalate degrading capacity, it 
possessed other good probiotic features such as strong autoaggregation ability and good 
antimicrobial activity. 
 
The 2 strains were tested to study their acid tolerance under conditions that mimic the 
gastrointestinal tract environment by exposing them to different pH conditions (Fig. 3.6). The strains 
were grown in MRS broth medium at pH 2 and pH 4 which was adjusted with HCl. The initial OD600 
for the two strains at 0 h was 0.1. The two strains hardly grew at pH 2, and the OD only increased to 
0.175 and 0.153 for L. gasseri 7(3) strain and L. reuteri 17(4), respectively, after 7 h of incubation. 
The cell growth of both strains was slightly higher at pH 4 than at pH 2, with L. gasseri 7(3) and L. 
reuteri 17(7) showing an OD increasing to 0.332 and 1.95, respectively. This was substantially lower 
than the control cells (pH 6.8) which reached final OD values of 2.623 and 4.837 for L. gasseri 7(3) 






Figure 3.6. Growth of Lactobacillus strains in the presence of acid. 
(a) L. gasseri 7(3) and (b) L. reuteri 17(7). The error bars indicate the standard error calculated from three 
replicates of the data. 
 
Even if the bacteria are unable to grow at low pH, their ability to remain viable under acidic 
conditions during transit through the stomach of the host, is one of the major criteria for selecting a 
potential probiotic (Tuomola et al., 2001). For that reason, the effect of acidic conditions on the 
viability of the two strains was evaluated under the various pH conditions (Fig. 3.7). The numbers of 
viable bacteria were determined at 0 and 6 h. At the beginning of the experiment, the viable count of 
the L. gasseri 7(3) and L. reuteri 17(7) was 7.6 × 107 and 4.91 × 107 c.f.u. ml-1, respectively. After 6 










Figure 3.7. The effect of pH on the viability of the Lactobacillus strains. 
(a) L. gasseri 7(3) and (b) L. reuteri 17(7) at pH 2 and 4. The error bars indicate the standard error calculated 
from three replicates of the data. 
 
At pH 4, however, the two strains maintained viability from time 0 to 6 h of incubation in a similar 
way to the control (pH 6.8). Taken together, Fig. 3.6 and Fig. 3.7, illustrate that exposure to pH 2 not 
only inhibits growth of the both strains, but it also actively kills the cells. At pH 4, there was a slight 
increase in cell viability of both strains with an increase in  the OD of the cultures. Although, the 
stomach pH can be as low as 1, the fact that these strains maintain some viability at pH 2 is thought 
to be a suitable criterion for selecting potential probiotic bacteria (Prasad et al., 1998). Moreover, 
once the food is ingested, the pH level in the stomach is raised, possibly due to the buffering capacity 
of the food. Hence the probiotic strains are unlikely to be exposed directly to a low pH environment 
like the stomach (Prasad et al., 1998). The ability of these strains to survive such conditions, could 
be based on maintaining the stable gradient between extracellular and cytoplasmic pH of the cell 
(Corcoran et al., 2005) (See Chapter 1). F0F1-ATPase is one of common mechanisms used by 
lactobacilli to protect themselves against acidic conditions (Cotter and Hill, 2003). Such mechanism 
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may have possibly assisted the L. reuteri 17(7) strain to resist low pH better than the L. gasseri 7(3) 
strain. 
 
3.3.7. Effect of bile salts on bacterial growth and viability 
For a bacterium to be used as a probiotic, it should be able to resist the effects of bile salts and bile 
secretions present in the small intestine. The concentration of bile in the intestine is appproximately 
between 0.2 to 2% (Gunn, 2000). Bile is known to be toxic to the bacterial cells, and thus it is 
important for the bacteria to develop a mechanism to survive in such hostile environment. L. gasseri 
7(3) and L. reuteri 17(7) strains were, therefore, screened to test their ability to tolerate bile salts.   
 
 
Figure 3.8. Growth of Lactobacillus strains in the presence of Oxgall bile salts. 
 (a) L. gasseri 7(3) and (b) L. reuteri 17(7). The error bars indicate the standard error calculated from three 
replicates of the data. 
 
The results showed that both the two strains were able to grow to varying extents in the different 
concentrations of bile tested. L. reuteri 17(7) tolerated bile extremely well and showed the same 
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growth characteristics as the control during growth in both bile concentrations (Fig. 3.8 b). L. gasseri 
7(3), however, also showed slightly decreased growth in the presence of bile (Fig. 3.8 a). 
 
Figure 3.9. The effect of bile salts on the viability of the Lactobacillus strains. 
(a) L. gasseri 7(3) and (b) L. reuteri 17(7) at concentrations of 0.5 and 1% of bile. The error bars indicate the 
standard error calculated from three replicates of the data. 
 
It was also interesting to examine the viability of the strains grown in the presence of 0.5 and 1% bile 
as compared to growth in the control medium (no bile added). Both strains retained their viability 
after 6 h of incubation under both conditions (Fig. 3.9). At the beginning of the experiment, the 
viable counts of L. gasseri 7(3) and L. reuteri 17(7) were 1.48 × 108 and 6.94 × 107 c.f.u. ml-1, 
respectively. After 6 h of incubation in the presence of 0.5% bile, the cell counts for L. gasseri 7(3) 
reduced slightly to 9.32 × 107, while they increased to 2.43 × 108 c.f.u. ml-1 for L. reuteri 17(7). A 
similar trend was also observed in cell viability at a bile concentration of 1%, where cell numbers 





The results indicated that there was an increase in the OD values for L. reuteri 17(7) in the presence 
of bile, which correlated with a corresponding increase in the number of viable cells. However, for 
the L. gasseri 7(3) strain, there was an increase in the OD values but a slight reduction in cell 
viability at 0.5 and 1% bile concentrations. This implies that, although the total mass of the culture, 
as measured spectrophotometrically increased, there was a simultaneous death of a certain number of 
the population as measured by viable count. The use of a LIVE/DEAD BacLight Bacterial Viability 
kit could possibly be used to demonstrate what fraction of population survived, when exposed to 
bile. BacLight staining has been shown to be a promising technique with several advantages 
(Lahtinen et al., 2005). It is reliable, rapid, and easy to use and yields both viable and total counts in 
one staining step.  The live and dead cells are distinguished based on their color. The viable bacteria 
fluoresce green, while the dead cells fluoresce red color. 
 
Overall, the two strains tolerated bile very well and maintained their viability over time. Thus, these 
strains may be likely to survive the harsh environment in human gut and retain their viabililty. The 
resistance of the two strains to bile salts could be due to the presence of BSH enzyme (Bile salt 
hydrolase), which eases the lethal effect of bile salts (Begley et al., 2005; Patel et al., 2009). The 
relationship between bile salts resistance and BSH enzyme activity patterns on these two strains 
should be investigated in further studies. 
 
3.4. Conclusion 
This study has evaluated important criteria that a potential probiotic bacterium should fulfill. The 
results have shown that the strains were resistant to kanamycin, vancomycin and streptomycin and 
had reduced susceptibility to chloramphenicol, rifampicin and erythromycin. If these antibiotics were 
used during antibiotic treatment, then the probiotics could survive and colonise the gut. The strains 
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were further tested for their antimicrobial activity, and they were able to inhibit the  pathogens tested. 
L. reuteri 17(7) and L. reuteri 16(9), in particular displayed high inhibition of the growth of 
pathogens, which indicated that they might provide health benefits to the host to lessen the risk of 
diseases. The Lactobacillus strains also demonstrated adhesion properties which may assist in 
colonizing the gastrointestinal tract to exert benefical effects (Charteris et al., 1998a). L. reuteri 
17(7) was one strain, that exhibited both good yeast agglutination and autoaggregation properties 
indicating that it would possibly adhere efficiently to colonic cells.  
 
The strains also showed the ability to degrade oxalate, with L. gasseri 7(3) possessing the highest 
oxalate degrading activity, which may be exploited further to reduce hyperoxaluria. The two oxalate 
degrading strains, L. gasseri 7(3) and L. reuteri 17(7), were selected for studies on their acid and bile 
tolerance. The strains were sensitive at pH 2, but tolerated pH 4 conditions well. They both also 
survived in the presence of 0.5% and 1% bile. Several studies have reported that the use of food 
ingredients enhances the survival of probiotic strain in the gastrointestinal tract (Charteris et al., 
1998b; Gardiner et al., 1999). It has also recently been documented that, the Lactobacillus strains 
could sequester metabolizable sugars to enhance their survival in an acidic environment (Corcoran et 
al., 2005). This suggests the possibility that these strains might adapt to pH 2 conditions during 
gastric transit by generating resistance mechanisms which enable their survival. The strains were 
further investigated for their genetic characteristics to determine their mechanism of oxalate 













Four Lactobacillus strains were screened by PCR for the presence of oxc genes using gene specific 
primers. The oxc gene was found to be present in all the 4 strains and this was confirmed by DNA 
sequencing of the PCR products. L. gasseri 7(3) was selected for further investigation of the 
transcription of the oxc gene in the presence or absence of 10 mM ammonium oxalate at pH 6.8 and 
5.5. Dot blot analysis of L. gasseri 7(3) mRNA transcripts revealed the gene was constitutively 
transcribed under both pH conditions regardless of whether oxalate was present or absent. This 
suggests that L. gasseri 7(3) may be a suitable probiotic candidate for the regulation of oxalate levels 























As reviewed in Chapter 1, oxalate-degrading bacteria generally use two enzymes to degrade oxalate. 
These are oxalyl-CoA decarboxylase (encoded by the oxc gene) and formyl-CoA transferase 
(encoded by the frc gene). The significance of these enzymes is that they make up approximately 
20% of total protein in the bacteria (Baetz and Allison, 1992) and have been shown to assist O. 
formigenes in degrading oxalate. The aforementioned enzymes are not as common in LAB, although 
they have been identified in L. gasseri Gasser AM63T (Lewanika et al., 2007) and L. acidophilus 
NCFM (Azcarate-Peril et al., 2006). Several studies have recently reported that pH has a possible 
effect on the expression of oxc and frc genes. For instance, Azcarate-Peril et al. (2006), used RT-
qPCR and microarray experiments to show that the oxc and frc genes were not expressed at pH 
above 5.8. Conversely, when the L. acidophilus cells were pre-incubated in MRS broth (pH 5.5) 
supplemented with noninhibitory concentrations of ammonium oxalate, the transcription levels of the 
oxc and frc genes were increased. This is also in agreement with a study by Lewanika et al. (2007), 
who confirmed that the oxc gene of L. gasseri Gasser AM63T was induced by oxalate under mildly 
acidic conditions (pH 5.5). The ability of the lactobacilli to utilize oxalate has, however, been shown 
to be strain and species specific (Turroni et al., 2007). 
 
Understanding the transcriptional regulation of gene expression is, therefore, an essential aspect of 
molecular biology studies. It plays a vital role in gaining insight into the signaling and metabolic 
pathways, which trigger the cellular processes, and it is, therefore, important to measure gene 
expression to determine the effect that several factors, including nutritional and environmental, might 
have in regulating gene expression (Trayhurn, 1996). There are numerous methods available that 
have been used to measure transcriptional regulation of genes (Reaue, 1998; Streit et al., 2009). 
These include northern blot analysis, DNA microarray evaluation, the ribonuclease protection assay 
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and quantitative reverse transcriptase polymerase chain reaction (RT-qPCR) among others. Northern 
blotting is a simple and specific method which has traditionally been used in studying gene 
expression. It is based on the separation of RNA according to size by agarose gel electrophoresis. 
The mRNA of interest is detected on the membrane using a hybridization probe with a base sequence 
complementary to all or a part of the sequence of the target gene (Trayhurn, 1996). Northern blotting 
is regarded as the only technique that provides detailed information about mRNA transcript size that 
cannot be obtained by the alternative methods (Bustin, 2000). However, it has some major 
drawbacks such as RNA degradation and low sensitivity (Streit et al., 2009). There are varieties of 
northern blotting techniques (dot, slot and fast blots) that have been developed to shorten the time 
taken for blot preparation and to improve semi-quantitative aspects (Reue, 1998). 
 
The ribonuclease protection assay can also be used to study gene expression. It also involves the 
hybridization of a labelled probe to a target mRNA, but differs from the northern blot in the respect 
that it is more sensitive, reliable and specific, and the hybridization occurs in a solution that contains 
both labelled antisense RNA probe and the target mRNA (Reau, 1998; Einspanier and Plath, 1998). 
DNA microarray analysis is a sensitive technique that simultaneously monitors the expression of 
thousands of genes in a single hybridization assay (Harrington et al., 2000). The microarray 
technology is based on the hybridization of RNA samples to either cDNA or oligonucleotides 
immobilized on a glass chip or nylon membrane (Weeraratna and Taub, 2007). The disadvantage of 
this technique is that it needs to be repeated numerous times to ensure reproducibility. Quantitative 
RT-PCR is the most sensitive method used to study gene expression and is useful in detecting low-
levels of mRNA transcripts (Bustin, 2000). It can be used to characterise patterns of mRNA 




The aim of the present study was to determine whether the oxc gene is present in 4 Lactobacillus 
strains which have previously been shown to degrade oxalate (Chapter 3) and to determine whether 
there was increased transcriptional regulation of the oxc genes at pH 6.8 and 5.5 in the presence of 10 
mM ammonium oxalate. 
For this preliminary study, northern blotting (dot blot assay) was selected to study the transcriptional 
regulation of the oxc gene because it is semi-quantitative, robust, sensitive and reliable (Yadetie et 
al., 2004).  
 
4.2. Materials and methods 
4.2.1. PCR identification for oxc genes 
Genomic DNA was extracted from all the Lactobacillus strains under investigation using the 
Genomic DNA Purification kit (Fermentas Life Science), and this was used as a DNA template for 
the 50 µl PCR reaction. The reaction mixture for the two L. reuteri strains contained; 200 ng of 
genomic DNA, 1.25 µl of each set of LRoxc (F) and LRoxc (R) primers at 10 µM (Table 4.1), 12.5 
µl of Kapa Ready Mix (Kapa Biosystems) and 9 µl of sterile distilled water. Amplification was 
performed on a thermocycler (GeneAmp® PCR system 9700, Applied Biosystems) with initial 
denaturation at 94oC for 5 mins, followed by 30 cycles of denaturation at 94oC for 30 sec, annealing 
at 53oC for 30 sec and elongation at 72oC for 30 sec, with a final elongation at 72oC for 5 mins. The 
reaction mixture for the two L. gasseri strains contained, 200 ng of genomic DNA, 1.25 µl of LGoxc 
(F) and LGoxc (R) primers (Table 4.1) at 10 µM, 5 U of Kapa Taq DNA polymerase (Kapa 
Biosystems), 0.5 µl of dNTPs, 1 µl of MgCl2 at 2.5 mM, 10× buffer A (Kapa Biosystems) and 16.25 
µl of sterile distilled water. The PCR amplification was performed with initial denaturation at 95oC 
for 5 mins, followed by 30 cycles of denaturation at 95oC for 30 sec, annealing at 50oC for 30 sec 
and elongation at 72oC for 30 sec, with a final elongation at 72oC for 7 mins. The PCR products were 
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visualised on a 0.8% agarose gel stained with ethidium bromide to detect the bands of correct 
molecular size. The PCR products were further purified using the Biospin PCR purification kit 
(BioFlux) and directly sequenced. The nucleotide sequencing was carried by the fluorescent 
dideoxynucleotide chain termination method (Sanger et al., 1977) using the MegaBACE 500 DNA 
sequencer (Amersham Pharmacia Biotech, Buckinghamshire, UK). The nucleotide and amino acid 
sequences were analysed and edited using the DNAMAN program package (Lynnon Corporation, 
Quebec, Canada) and further analysed on-line using the BLAST server at the NCBI sequence 
database (http://www.ncbi.nlm.nih.gov). 
 
Table 4.1. Description of primers used 


















 200 Nadkarni et 
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4.2.2. Expression of oxc genes  
4.2.2.1. Oxc induction and RNA extraction 
The method used was a modification of that of Azcarate-Peril et al. (2006). The L. gasseri 7(3) strain 
was grown anaerobically at 37oC for 20 h in either ½ strength MRS broth (control) or ½ strength 
MRS broth supplemented with 10 mM of ammonium oxalate. The cultures were grown over 2 
consecutive days to induce the expression of the L. gasseri 7(3) oxc gene. The cells were transferred 
to either ½ strength MRS broth (pH 6.8) or ½ strength MRS broth (pH 6.8) supplemented with 10 
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mM ammonium oxalate, and incubated at 37oC under anaerobic conditions. The cell growth of the L. 
gasseri 7(3) strain was monitored spectrophotometrically (OD600) for 24 h using the S1000 Diode 
Array Spectrophotometer (Labotec). The cell cultures were collected after 8 h growth corresponding 
to the mid-log phase for both ½ strength MRS broth (pH 6.8) and ½ strength MRS broth (pH 6.8) 
supplemented with 10 mM of ammonium oxalate. In a separate experiment, the above procedure was 
repeated, except that the cells were transferred to ½ strength MRS or ½ strength MRS with oxalate, 
adjusted to pH 5.5 with lactic acid. Thereafter, total RNA was extracted using the method of Aiba et 
al. (1981), and purified using the RNeasy Mini Kit (Qiagen). The quality of RNA was assessed by 
visualizing it on an ethidium bromide stained denaturing formaldehyde agarose gel. The RNA 
concentration was determined using a NanoDrop® ND-1000 spectrophotometer (Nanodrop 
Technologies).  
 
4.2.2.2. Dot blot hybridization  
DNA probes for hybridization to the RNA were prepared by PCR of a 400 bp, internal fragment of 
the Lactobacillus gasseri oxc gene amplified with the primers LGox (F) and LGox (R) (Table 4.1). 
As a control, a probe for the L. gasseri 16S rRNA gene was prepared using the universal primers 
denoted as 16S (F) and 16S (R) (Table 4.1). Equal amounts of the total RNA extracts from ½ 
strength MRS and ½ strength MRS supplemented with 10 mM of ammonium oxalate were blotted on 
to a nylon membrane (Hybond-N+, Amersham Biosciences) and fixed to the membrane by exposure 
to UV for 5 mins. This was followed by hybridization with the oxc and 16S rRNA gene specific 
probes and chemiluminiscent detection with CSPD® substrate was performed according to the 
manufacture’s guidelines (Roche Diagnostics GmbH Mannheim, Germany). The hybridization 
signals of the experimental samples were visualised using a Molecular Imager® ChemiDocTM XRS 
Imaging system, and compared to the 16S rRNA gene control.  
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4.3. Results and Discussions 
4.3.1. PCR identification of oxc genes 
In Chapter 3, it was reported that all the 4 Lactobacillus strains evaluated had the capacity to degrade 
oxalate to varying degrees. These strains were natural isolates with unknown genome sequences, 
and, therefore, it was important to investigate whether this oxalate degradation was occurring via the 
oxc mediated oxalate degradation pathway. The presence of the oxc gene was detected by carrying 
out a PCR using oxc gene specific primers of the L. gasseri and L. reuteri oxc genes (Table 4.1). The 
oxc primers were designed using the DNAMAN program package (Lynnon Corporation, Quebec, 
Canada) by aligning the L. gasseri and L. reuteri oxc gene sequences obtained from the NCBI 
GenBank. The specificity of these primers to bind specifically to the oxc gene was confirmed by 
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Figure 4.1. Clusters of genes encoding putative oxalate degrading enzymes (a) L. gasseri (NC_008530.1) and 
(b) L. reuteri (NC_009513.1). The arrows indicate the positions where the primers bind to the oxc gene. 
 
The results gave the expected PCR product sizes (Fig. 4.2) and the DNA sequencing results 
confirmed that these were internal fragments of the oxc gene as compared to the oxc sequences found 






Figure 4.2. Agarose-gel electrophoresis of amplified oxc genes from genomic DNA of the 4 strains 
Lactobacillus. Lane M, (λ DNA digested with PstI); Lane 1, L. gasseri 7(3); Lane 2, L. gasseri 17(4); Lane 3, 
L. reuteri 17(7); Lane 4, L. reuteri 16(9) and Lane 5, Negative control (no DNA). 
 
The oxc gene involved in oxalate degradation has been found in other Lactobacillus species such as, 
L. acidophilus (Azcarate-Peril et al., 2006) and L. gasseri (Lewanika et al., 2007). The identity of the 
internal oxc gene fragment of the 4 Lactobacillus strains was compared to the oxc gene of L. gasseri 
(CP000413.1) and L. reuteri strains (CP000705.1) at the amino acid level. The internal fragment of 
L. gasseri 7(3) and L. gasseri 17(4) had 91.71% and 100% amino acid identity to the L. gasseri oxc 
gene (Lgas_0248), while L. reuteri 17(7) and L. reuteri 16(9) had 100% amino acid identity to the L. 
reuteri oxc gene (Lreu_0494), respectively. 
 
Turroni et al. (2007) investigated the oxalate degrading ability of a number of L. reuteri strains, and 
found that they had no oxalate degrading activity. Nevertheless, the genome sequences of L. reuteri 
JCM 1112 (NC_010609) and L. reuteri DSM 20016 (NC_009513.1) available in GenBank databases 
have been shown to include oxc genes. The lack of oxalate degrading capacity in the L. reuteri 
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studies may, therefore, depend on the in vitro assay conditions, or on the functionality of the oxc 
gene in these strains. The L. reuteri 17(7) and L. reuteri 16(9) strains used in this study also 
possessed an oxc gene and these strains both showed moderate oxalate degrading ability (Chapter 3). 
In summary, the four strains have been shown to posses an oxc gene which encodes the oxalyl-CoA 
decarboxylase enzyme that participates in oxalate catabolism. 
 
4.3.2. Investigating the expression of oxc genes in L. gasseri 7(3) 
Among the 4 Lactobacillus strains, L. gasseri 7(3) was selected to investigate the expression of oxc 
genes, because it had high oxalate degrading activity (approximately 33%) and possessed very good 
probiotic characteristics. These included good antimicrobial activity against pathogenic bacteria, 
adhesion properties, as well as tolerance of low pH and high concentration of bile salts.  
 
In order to evaluate the effect of oxalate and pH on the growth of L. gasseri 7(3), the strain was 
grown in ½ strength MRS broth (pH 6.8 or 5.5) and ½ strength MRS broth (pH 6.8 or 5.5) 
supplemented with 10 mM of ammonium oxalate. The growth curve of preadapted L. gasseri 7(3) 
cells in the presence of 10 mM ammonium oxalate as compared to uninduced cells (Fig. 4.3) 
demonstrated that there was very little difference between the growth of L. gasseri 7(3) under these 
various conditions, although the presence of oxalate did result in slightly slower growth in the 








Figure 4.3. The effect of oxalate and pH on the growth of L. gasseri 7(3). Cells were grown in ½ strength 
MRS broth and ½ strength MRS broth supplemented with 10 mM of ammonium oxalate (AmOx) at (a) pH 
6.8 or (b) pH 5.5. The error bars indicate the standard error calculated from three biological experiments. 
 
RNA dot blot analysis was performed to investigate the transcription of the oxc gene in the L. gasseri 
7(3) strain in the presence or absence of 10 mM ammonium oxalate at pH 6.8 and pH 5.5. Under 
these conditions, transcripts were obtained when LGoxc specific probe was hybridized with total 
RNA isolated from cells at mid-log phase at time 8 h (Fig. 4.3). The 16S rRNA gene probe was used 
as a control to normalize the signal obtained from the experimental samples.  
 
Figure 4.4. Transcriptional analysis to assess oxc gene expression in pre-adapted L. gasseri 7(3) at pH 6.8 and 
5.5. RNA was isolated at mid-log phase. U: Uninduced ½ strength MRS broth; I: Induced ½ strength MRS 
broth at 10mM of ammonium oxalate. The experiment was done in 3 biological and 2 technical experiments. 
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The dot blots showed that there was no difference in the levels of transcription of the oxc gene at 
either pH or in the presence or absence of oxalate (Fig. 4.4). The ability of L. gasseri 7(3) to express 
the oxc gene in the absence of oxalate indicates that the strain can transcribe the gene constitutively 
and that the gene product would be available for oxalate degradation even in the presence of alternate 
carbohydrate substrates. Interestingly, these results are different from the findings of Lewanika et al. 
(2007), who observed that oxc gene of L. gasseri Gasser AM63T was not expressed in the absence of 
oxalate at mid-log phase. This suggested that the presence of oxalate in the medium could have 
induced the expression of putative oxc gene under mildly acidic conditions (pH 5.5), although, the 
transcriptional analysis of L. gasseri Gasser AM63T strain was not studied under pH 6.8 conditions. 
However, it should be emphasised here that Lewanika et al. (2007) used strain L. gasseri Gasser 
AM63T and in this study the natural isolate, L. gasseri 7(3) was used. The L. gasseri 7(3) strain might 
have a mutation in a regulatory protein or DNA regulatory sequence, which might allow the oxc gene 
to be transcribed even in the absence of oxalate. 
 
The findings of Azcarate-Peril et al. (2006) were, however in some ways similar to our findings, 
although L. acidophilus NCFM was used to study the transcriptional analysis. The L. acidophilus oxc 
gene was found to be transcribed in the absence of oxalate under acidic conditions (pH 5.5). 
However, the genes showed markedly increased expression in the presence of 35 mM of ammonium 
oxalate at pH 5.5. In their study, however, when 70 mM of ammonium oxalate was added at pH 6.8, 
transcriptional of the gene was not induced and this could possibly be due to the dissociation of the 
oxalic acid.  
  
This study suggests that the L. gasseri 7(3) strain has a potential role in degrading oxalate, even in 
the presence of other possible carbon sources. L. gasseri 7(3) can, therefore, be considered as a 
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“generalist” oxalotroph, because it is able to utilize alternative substrates as well as oxalate. They are 
able to thrive in a wide variety of environmental conditions and use different resources as their 
source of energy. This finding is clinically important with respect to intestinal reduction of oxalate, 
because L. gasseri 7(3) will be able to degrade oxalate in the presence of alternative energy source. 
This is different from the “specialist” oxalotroph, O. formigenes, which utilizes oxalate as its sole 
source of energy (Sahin, 2003).  
 
4.4. Conclusion 
The four Lactobacillus strains have been shown to possess oxc genes, which encode oxalyl-CoA 
decarboxylase. This is significant because of its potential contribution to the detoxification of oxalate 
present in human and animal intestinal tracts (Sidhu et al., 1997). The present study provided an 
insight into transcriptional regulation of L. gasseri 7(3) in the presence or absence of oxalate under 
different pH conditions. Variation in pH did not influence the expression of oxc gene negatively, 
suggesting that the strain could possibly adapt to the physiological conditions. In addition, this strain 
was shown to possess a “generalist” character, indicating that it utilizes oxalate as well as alternative 
carbon sources for energy. Further analysis of oxc gene expression is, however, required either using 
microarray or RT-qPCR in order to validate the results of the dot blot analysis as these techniques 
have been shown to be more sensitive and specific. Similarly, it would be useful to screen for the frc 
gene in the four Lactobacillus strains. In particular, the transcriptional regulation of frc gene in L. 










GENERAL CONCLUSION AND FUTURE STUDIES 
In this study four Lactobacillus strains isolated from faecal samples of healthy human individuals 
were identified to the species level. It was hypothesised that these strains might have the ability to 
degrade oxalate and could be useful in the development of probiotics for the treatment of kidney 
stone disease. The identification of these strains was important as this helps to assess, which of the 
human intestinal microbiota may eventually be used as probiotics. The strains were identified as L. 
gasseri 7(3), L. gasseri 17(4), L. reuteri 17(7) and L. reuteri 16(9) and were autochothonous strains, 
defined as natural isolates. The probiotic potential of the Lactobacillus strains was also assessed by 
determining their antibiotic resistance characteristics, their antimicrobial activity against pathogens, 
their adhesion properties, their tolerance to low pH and bile salts, and their oxalate degrading 
activity. The strains displayed good probiotic properties and had good oxalate degrading activity 
(Table 4.1).  
 
Table 4.1: Summary of the criteria recommended for selecting potential probiotic strains  
Strains Antimicrobial 
activity  





Acid survival Bile surival Oxalate 
 utilization 
L. gasseri 7(3) 5 ++ ++ pH 2: NG 









L. reuteri 17(7) 7 +++ +++ pH 2: NG 









(G) growth, (NG) no growth 
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Overall, L. gasseri 7(3) was shown to be the best potential probiotic bacterium of the study. It 
displayed antimicrobial activity against most of the pathogens tested, good yeast agglutination and 
autoaggregation properties, acid (pH 2 and pH 4) and bile (0.5% and 1%) tolerance and had the 
highest oxalate utilization ability.  
 
Further in vivo study is, however, needed to confirm the probiotic properties of these Lactobacillus 
strains. This highlights the need for animal studies and double blind placebo controlled clinical trials 
using a large cohort of human participants, to evaluate the safety and efficiacy of the probiotics and 
the ability to reduce the urinary oxalate excretion in participants with kidney stone disease. The 
strains were also screened for the presence of the oxc gene and they were shown to possess these 
genes, which encode oxalyl-CoA decarboxylase that is considered crucial in the detoxification of 
oxalate present in human and animal intestinal tracts. Of the 4 strains tested, L. gasseri 7(3) 
possessed good probiotic characteristics with excellent oxalate degrading activity. It was therefore, 
selected to study the transcriptional regulation of the oxc gene in the presence and absence of 10 mM 
of ammonium oxalate under mildly acidic and no acidic conditions. The oxc gene was constitutively 
transcribed under both pH conditions in the presence and absence of 10 mM ammonium oxalate. 
This observation suggested that, it could possibly be due to several transcriptional factors or possibly 
mutation. Future work is needed to further characterise the regulatory mechanisms controlling the 
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